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1 INTRODUCTION
Classically, nutrient requirements have been based mainly on the amounts of nutrients
needed to both prevent deficiencies and to maintain body stores of the nutrients. Over the
last decade attention has increasingly focussed on using the reduction in risk of chronic
disease as the basis for establishing nutrient requirements. This requires insight into the
causal link between micronutrient intakes and either disease or health outcomes of public
health concern. At the same time, it is now well recognised that optimal nutrition during
pregnancy, lactation and infancy has long-term effects on child health, well-being and
performance, extending into adulthood and old age. Despite the importance of early nutrition,
conducting studies in infants and children and in pregnant and lactating women has
important ethical limitations, and few adequate studies have been performed in infants and
children. Thus, the available scientific database on the nutritional requirements of these
populations is limited. Their nutrient requirements are therefore often based on approaches
which ignore the long-term effects of nutrition.
The physiological requirement of a nutrient is defined as the amount and chemical form of
the nutrient needed systematically to maintain normal health and development, without
disturbance of the metabolism of any other nutrient and without extreme homeostatic
processes and excessive depletion or surplus of bodily reports (Aggett et al., 1997). The
corresponding dietary requirement would be the intake sufficient to meet the physiological
requirement taking into account aspects such as the absorption of the nutrient from the diet.
The nutrient requirement differs between individuals, and the recommended intake (value of
reference for intake of a certain nutrient) for a certain population aims to cover the nutrient
requirement of almost all individuals in that population (Pijls et al., 2009). Thus, reference
values for nutrient intake do not refer to individuals, but are set for populations defined by
age, gender and in some cases additional characteristics that are relevant for nutrient needs.
They are used for assessing the adequacy of dietary intakes of populations and for planning
desirable dietary intakes, and they are part of the basis for food and nutrition policies such as
the development of food based dietary guidelines, food fortification and enrichment
programmes, food regulations and trade, and nutritional education. They are also used in
nutrition labeling because the amount of a nutrient contained in a portion or in 100g is
expressed as a percentage of a nutrient reference value (Ashwell et al., 2008).
Most European countries have set reference values for nutrient intake for several population
groups: for instance, for age groups (infants, children and adolescents, adults, elderly) and
for population in special life stages (pregnant women, women who are lactating). The
Netherlands, the United Kingdom, France, Latvia, Lithuania, the Nordic countries (Norway,
Sweden, Finland, Denmark and Island), and Germany, Austria and Switzerland (DACH
countries), published their own standards. Other countries based their reference values on
those from other countries and organizations (Doets et al., 2008). The European Union's
Scientific Committee for Food produced its own report, Nutrient and Energy Intakes for the
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European Community. Outside Europe, the United States and Canada issued their own
values, as well as Australia and New Zealand. At a global scale, the World Health
Organization together with the Food and Agriculture Organization has also set reference
values for nutrient intake.
Variability of reference values for micronutrient intake
Current reference values for micronutrient intake vary considerably across Europe. For
example, for children at 5 years of age, there is a twofold difference between the value given
fpr orpm by the German, Austrian and Swiss Nutrition Societies (DACH) and the value set by
the European Union’s Scientific Committee for Food. Table 1 illustrates differences of
reference values for iron intake established by four different committees for some population
groups and life stages. Variability is caused by various factors, e.g. disparities that exist
between underlying concepts, the terminologies used and the methodologies and
assumptions that have been made in the process of defining micronutrient requirements and
deriving reference values for intake (Doets et al., 2008). Committees and expert groups
tasked with the setting of reference values have used for their purposes the scientific
evidence available at a certain point of time. This also contributes to variation, because
reference values have evolved with the progress in science. Also, values are set for different
population groups, but the definition of population groups is not consistent across Europe.
For instance, reference values for infants are set for two up to four age groups in the first
year of age. When establishing reference values, committees have considered different
population characteristics such as the life cycle, physical activity level, smoking and
bioavailability. When scientific reports informing about the process are available,
transparency is in general not very well accomplished. In case there is transparency, there
are enormous differences in the type of evidence used, in the selection of endpoints
selected, and in the selected criteria for adequacy. Often, experts’ opinions are used. When
no scientific data are available to establish the requirements of certain groups (e.g. young
children), extrapolation and interpolation methods between age groups are used, and these
methods often differ (Doets et al., 2008).
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Table 1: Comparison of current reference values for iron intake (mg/day) established for different ages
and life stages.
Source; Nutri-RecQuest (Cavelaars et al., 2010)
(http://www.serbianfood.info/eurreca/index.php)
Infants
3 months
Infants
9 months
Children
5 years
Children
10 years
Adolescents
15 years
Lactating
women
35 years
NPNL*
women
35 years
EC - § 6 4 6 19 10 15
Netherlands 5 7 7 7 12 20 15
DACH 0.5 8 8 15 15 20 15
WHO - § 10.5 7 7 35 17 33
§ Reference value not established for infants younger than 6 moths
* Non-pregnant, non-lactating
The need for the harmonisation of reference values for micronutrient intake across Europe
was recognised by the European Commission’s Directorate-General Research in EC Call
T5.4.2.1 entitled “Nutrient status and requirements of specific population groups”. In
response to this call, funding for the EURRECA Network of Excellence (NoE) was then
started for the period 2007–2011. ‘EURRECA’ stands for EURopean RECommendations
Aligned and its full name is aligning micronutrient recommendations across Europe with
special focus on vulnerable groups and consumer understanding (Pijls et al., 2009) .
EURRECA attempts to consolidate the basis for the definition of micronutrient requirements
across Europe (Ashwell et al., 2008).
Some initiatives already exist to overcome this fragmentation. A large variety of terms are
used to define reference values worldwide, because several committees have created their
own terminology: Dietary reference values (DRVs) used by UK, nutrient reference values
(NRVs) used by Australia and New Zealand, reference values for nutrient intake used by the
DACH countries, and dietary reference intakes (DRIs) used by US and Canada. Although
these terms describe very similar concepts, their meanings are not exactly the same, which
still causes considerable confusion. A group of international experts convened by the United
Nations University’s Food and Nutrition Programme, in collaboration with the Food and
Agricultural Organization (FAO), the World Health Organization (WHO), and the United
Nations Children’s Fund (UNICEF) has agreed on the term nutrient intake values (NIVs),
which encompasses all nutrient-based dietary standards derived from primary data and
provide estimates on appropriate dietary substrate supply for populations of healthy people.
The UNU Working Group has defined the following NIVs: Average nutrient requirement
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(ANR), individual nutrient level (INL) and upper nutrient level (UNL). ANR is the estimated
average or median requirement of a specific nutrient in a population, derived from a
statistical distribution of requirement criterion and for a particular age and sex specific group
based on a specific biological endpoint or biochemical measure. It is assumed that individual
requirements follow a statistical distribution (symmetrical bell-shaped curve). INL is the
individual nutrient level and INL97 is the nutrient intake considered adequate to meet the
known nutrient needs of practically all healthy individuals in a particular age and sex-specific
group. Equivalent terms are population reference intakes (PRI) and recommended dietary
allowance (RDA). This value, set at a level of intake that meets the needs of the majority of
the population (mean + 2SD), is generally used as the target for provision of essential
nutrients to populations and as the reference point for nutrient labelling of foods. The
exception is energy, for which the ANR is used because the use of INL97 or equivalents
would lead to overfeeding. UNL is the highest level of daily nutrient intake that is likely to
pose no risk of adverse health effects for almost all individuals of a particular life-stage group
(King and Garza, 2007).
An agreement on terms and definitions is an important step towards the harmonisation of
reference values. Equally important is the consolidation of the scientific basis for the
definition of micronutrient requirements. There are two ways of helping this consolidation:
First, understanding the differences between established micronutrient requirements and
derived values for recommended intakes (e.g. methodological differences). Second, updating
the scientific basis on which the requirement for a micronutrient can be based by reviewing
the current best evidence available. Systematic reviews of the evidence provide a
transparent and rigorous evidence review process for the expert committees and facilitate
the update of reference values as new data become available (Chung et al., 2010).
EURRECA is conducting systematic reviews on those micronutrients that are deemed to be
of major importance for certain population groups, following a standardised methodology.
The research reflected in the three publications included in this dissertation exemplifies the
two approaches. This research was carried out in the frame of the EURRECA Network of
Excellence. The first two manuscripts tackle issues relevant to the determination of
micronutrient requirements of lactating women and of infants until the 12th month of life. This
includes physiological factors, definitions and specific terms as well as methodological
approaches used to establish reference values for micronutrient intake in these population
groups. The sources of variation between current established requirements and reference
values for micronutrient intake are pointed out. The third manuscript reports a systematic
review of randomised controlled trials assessing the effect of iron supply on two important
functional outcomes of infants, children and adolescents: 1) neurodevelopment (including
cognition and psychomotor development) and 2) immune function. This review represents an
update of the available evidence on the effect of iron on those two important outcomes, and
its results should help making decisions on the optimal level of iron required from birth to
puberty.
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Considerations on the micronutrient requirements of lactating women and infants and
derived reference values for micronutrient intake
Lactating women
There are difficulties and ethical limitations in conducting research in women during
reproductive stages, so metabolic data on which nutritional requirements are often based are
lacking for this physiologically important stage of life. Requirements of nutrients in lactating
women are therefore established applying a factorial method: the nutrient need of a woman
who is lactating is calculated by summing the nutrient need of a non-lactating woman of
similar periconceptional age, and the amount of nutrient secreted into an average volume of
breast milk, making some adjustments for bioavailability in some cases. Although
committees apply similar extrapolation methods to calculate requirements, reference data
applied for nutrient composition of milk disparate (Atkinson and Koletzko, 2007). There are a
number of aspects which should be considered when defining the nutritional requirements of
healthy women during the lactation period. The second publication of this dissertation
addresses challenges for establishing reference values for micronutrient intake in this
population group and factors which can have a modifying impact on reference values, such
as the variability of breast milk volume and composition, stages of lactation, maternal age
(adolescent pregnancy), birth spacing and the duration of the recuperative interval, diet,
lifestyle, socioeconomic and cultural factors, and the effect of maternal nutritional status. A
comparison of reference values for micronutrient intakes for lactating women used in
European countries as well as the level of change compared to reference values for non-
pregnant, non-lactating women is provided.
Infants
Infancy is characterized by growth and development, which impose unique nutritional needs
upon the already high maintenance needs of infants. Few quality studies have been
performed in this age group, and the nutritional requirements of infants have been
established through indirect methods such as usual intakes of presumably healthy
populations, factorial approaches that take into account the amount of nutrient needed for
growth and the amount lost in the body, and balance techniques. The first paper of this
dissertation summarises and critically evaluates the methodological approaches followed to
establish the micronutrient requirements of healthy infants and to derive reference values for
micronutrient intake from those requirements. A sample of seven countries/committees which
set their own reference values (not based on the reference values set by other
countries/committees) and for which background reports were available, was used for this
analysis. The publication also gives an overview of the latest knowledge on nutritional
requirements (macronutrients and micronutrients) of infants in early and late infancy.
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The effect of iron supply on the neurodevelopment and immune function of infants,
children, and adolescents
Iron is a critical substrate for infants, children and adolescents. This is due, on one side, to
rapid growth, hemoglobin expansion and development experimented during those periods;
and, on the other side, due to the increased need for iron. Especially infants are considered a
vulnerable group because they have a relatively high requirement of nutrients per unit body
weight during a sensitive period of rapid growth and development. Adolescent girls are
another risk group due to menstrual losses. However, there are still open questions on the
adequate iron intakes during these periods of life and subsequently, on the dietary intake of
iron to recommend, and also for instance to put in infant formula.
Ideally, the definition of micronutrient requirements would take into account relationships
between micronutrient intakes in the diet and health outcomes. In the absence of primary
data from quality studies linked to functionally relevant outcomes, calculations of the
physiological requirement for absorbed iron for infants, children and adolescents are
currently based on factorial modelling. The components of iron requirement used as factors
in the modelling include basal iron losses, menstrual losses, increased requirement during
growth for the expansion of blood volume, and/or increased tissue and storage iron. This
approach does not address the issue of iron intake supporting long-term health and optimal
functional capacities rather than just avoiding acute deficiency states.
Observational studies have shown that iron deficiency and iron deficiency anemia can have a
serious impact on infants’ and children’s health and later development: alteration of the
immune status, adverse effects on morbidity, delayed behavioural and mental development,
below average school achievements and growth retardation. The clearest evidence between
diet and health is found when observational studies are confirmed by experimental studies.
Although some studies have been performed using health outcome to assess iron
requirement in infancy, childhood and adolescence, results have been inconclusive.
Therefore, a systematic review was carried out to review and update the best evidence
available from randomised controlled trials assessing the effects of iron intake on measures
of neurodevelopment, including cognitive and psychomotor development, and on immunity in
infants, children and adolescents. That is the object of the third manuscript included in this
dissertation.
List of publications included in this dissertation
 Publication 1: Hermoso, M., G. Tabacchi, I. Iglesia-Altaba, S. Bel-Serrat, L. A.
Moreno-Aznar, Y. García-Santos, M. d. R. García-Luzardo, B. Santana-Salguero, L.
Peña-Quintana, L. Serra-Majem, V. H. Moran, F. Dykes, T. Decsi, V. Benetou, M.
Plada, A. Trichopoulou, M. M. Raats, E. L. Doets, C. Berti, I. Cetin & B. Koletzko
(2010) The nutritional requirements of infants. Towards EU alignment of reference
values: the EURRECA network. Maternal & Child Nutrition, 6, 55-83.
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 Publication 2: Hall Moran, V., N. Lowe, N. Crossland, C. Berti, I. Cetin, M. Hermoso,
B. Koletzko & F. Dykes (2010) Nutritional requirements during lactation. Towards
European alignment of reference values: the EURRECA network. Maternal & Child
Nutrition, 6, 39-54.
 Manuscript 1*: Hermoso, M., V. Vuvic, C. Vollhardt, C., A. Arsic, B. Roman-Viñas, I.
Iglesia-Altaba, M. Gurinovic. & B. Koletzko. Iron and neurodevelopment and immunity
in infants, children and adolescents: a systematic review. (submitted in February
2011)
* Manuscript 1 has been submitted for publication and is still under revision.
Appendix A includes the search strategy used to carry out the search in electronic databases
for the systematic review reported in Manuscript 1.
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revision of literature on the nutrient requirement of infants, description of approaches
used to establish requirements and reference values, detailed comparison of methods
used to establish requirements and reference values for vitamins by a sample of
seven committees, conclusions and discussion, and revision of the manuscript and
integration of reviewers’ comments towards publication.
 Publication 2: comparison of current reference values for micronutrient for lactating
women and comparison of values compared to non pregnant-non lactating women,
revision of the methodological approaches to derive reference values for lactating
women, and critical revision of the draft.
 Manuscript 1: selection of health outcomes in the infant population group for the
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Exploration of possibilities for meta-analysis, preparation of the draft manuscript,
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5 SUMMARY
Current reference values for micronutrient intake vary considerably across Europe. Variability
is caused by several factors, including the disparities that exist between underlying concepts,
the terminologies used, the methodologies and assumptions that have been made in the
process of defining micronutrient requirements and deriving reference values for intake, and
the time point at which references have been set. This causes confusion among decision
makers, health professionals, and consumers. Updated, solid evidence on which
micronutrient requirements can be based, and identification of factors leading to differences
in reference values are important for informing future initiatives aimed at providing
standardized approaches to overcome variability of micronutrient reference values across
Europe. Ideally, the definition of micronutrient requirements takes into account relationships
between micronutrient intakes in the diet and health outcomes. Sometimes, there are no
sufficient primary data from quality studies linked to functionally relevant outcomes. This is
the case of iron. Iron is a critical substrate for infants, children and adolescents due to the
rapid growth and development experimented during those periods of life and the increased
iron needs. However, there is controversy about the adequate level of iron they need.
The present work presents a review of current knowledge regarding the micronutrient
requirements of specific population groups (lactating women, infants, children and
adolescents). A particular focus is put on iron requirements.
Reference values for micronutrient intake used in European countries for infants and for
lactating women were analysed to determine the methodological approaches followed to
derive them. The main issues contributing to disparities in micronutrient reference values for
infants and for lactating women were highlighted, as well as the physiological factors that
play a role in the estimation of micronutrient requirements.
A systematic review was conducted to summarize the evidence currently available from
randomized controlled trials (RCT) concerning the effect of iron supply of infants, children
and adolescents until 18 years of age on measures of neurodevelopment, and on immunity.
The Cochrane Library, MEDLINE and EMBASE were searched up to and including February
2010. Studies were also identified by checking the bibliographies of the articles retrieved.
Studies were considered from inclusion in the systematic review if they complied with the
following criteria: RCTs with an adequate control group; iron supply provided by natural food
sources, supplements, formula, or fortified foods; studies carried out in infants, children and
adolescents until the age of 18 years, and parameters relevant to the selected outcomes
measured. No language restrictions were applied.
The selected articles were evaluated and data were extracted in a standardized form. The
internal validity of the studies was assessed based on indicators specific to the RCT
methodology. Based on these indicators, the overall risk of bias was determined and
classified as high, moderate, or low.
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The results and conclusions deduced from this work can be summarized as follows:
1. Following reasons were identified as main factors for the existing variety in established
reference values for intake for infants: the conversion of requirements into reference
values differently on the basis of body weight or of energy intake without explaining
normative data used, the variety of extrapolation methods applied, and the establishment
of different age groups in the first 12 months of life without a clear rationale other than the
transition from milk to foods.
Differences in the normative data used for extrapolating requirements for lactation is the
main source of variation of reference values for intake for healthy lactating women.
In general, there is a serious lack of transparency in the process of establishing
micronutrient requirements and reference values for intake for both population groups
2. For the systematic review, 13 supplementation studies met the selection criteria for
neurodevelopment and 7 for immunity. Most of the studies had a high or moderate risk of
bias.
Due to the variety of results reported, it is difficult to derive clear conclusions for the
outcome neurodevelopment. Overall, the studies showed a modest positive effect of iron
supplementation on cognition and psychomotor outcomes, especially after long-term
supplementation periods (>2 months) and in anemic infants and children.
A comparison of studies using immunity outcome was not possible due to the
heterogeneity of the parameters tested in the different studies. Currently available
evidence is too incomplete to make evidence-based conclusions on the effect of iron on
immunity.
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6 ZUSAMMENFASSUNG
Referenzwerte für die Mikronährstoffzufuhr unterscheiden sich sehr stark zwischen den
einzelnen europäischen Staaten. Der Zeitraum in dem die nationalen Richtlinien überprüft
werden, die verschieden verwendeten Methoden zur Bestimmung des
Mikronährstoffbedarfes, die unterschiedlichen Konzepte zur Darstellung von Referenzwerten,
tragen unter anderem dazu bei, dass eine große Variationsbreite zwischen den
Referenzwerten zu Stande kommt. Daraus resultiert eine große Unübersichtlichkeit für
politische Entscheidungsträger, Gesundheitsexperten und Verbraucher. Eine fundierte
wissenschaftliche Grundlage, die die Einschätzung des Bedarfs der Mikronährstoffe
ermöglicht, und die Identifizierung der Faktoren die zur Variation zwischen Referenzwerten
führen, sind wichtig, um zukünftigen Initiativen zur Harmonisierung von Referenzwerten für
die Mikronährstoffzufuhr zu dienen und Unterschiede innerhalb Europas zu überwinden.
Idealerweise wird der menschliche Bedarf an Mikronährstoffen in Zusammenhang mit
gesundheitlichen Zielparametern bestimmt. Oft ist aber die Datenlage aus klinischen Studien
nicht ausreichend, um den Bedarf mittels klinischer Evidenz festzulegen. Ein Beispiel hierfür
stellt das Eisen dar. Besonders während des Wachstums besteht ein erhöhter Eisenbedarf.
Allerdings ist die Höhe des Eisenbedarfs von Säuglingen, Kindern, und Jugendlichen
umstritten.
Gegenstand dieser Arbeit ist die Darstellung aktueller Kenntnisse bezüglich des
Mikronährstoffbedarfs bestimmter Bevölkerungsgruppen (stillende Frauen, Säuglinge, Kinder
und Jugendliche). Ein besonderer Fokus wird auf den Eisenbedarf gelegt.
Auf europäischer Ebene vorliegende Referenzwerte zur Mikronährstoffzufuhr für stillende
Frauen und Säuglinge wurden daraufhin untersucht, welche methodischen Ansätze zur
Entwicklung dieser Referenzwerte angewendet worden waren. Dabei wurde hervorgehoben,
welche Faktoren zu Unterschieden führen, und welche physiologischen Faktoren bei der
Bestimmung des Mikronährstoffbedarfs eine Rolle spielen.
Eine umfassende systematische Literaturübersicht wurde durchgeführt mit dem Ziel, alle
randomisierten kontrollierten Studien (RCT) zu identifizieren, in denen die Wirkung der
Eisenaufnahme von Säuglingen, Kindern und Jugendlichen bis zum 18. Lebensjahr in Bezug
auf die Zielgrößen Neuroentwicklung und Immunität geprüft wurden. Die Cochrane Library,
MEDLINE und EMBASE wurden bis einschließlich Februar 2010 durchsucht. Die
Literaturverzeichnisse der ausgewählten Studien wurden auf weitere relevante Artikel
geprüft. RCTs mit einer adäquaten Kontrollgruppe, die die Eisenversorgung aus
Lebensmitteln, Supplementen, Säuglingsnahrung oder angereicherten Lebensmitteln bei
Säuglingen, Kindern und Jugendlichen bis zum 18. Lebensjahr prüften, und die Bestimmung
ausgewählter Zielparametern durchführten, wurden eingeschlossen. Die Sprache der Artikel
stellte hierbei kein Auswahlkriterium dar.
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Die jeweiligen Artikel wurden begutachtet und ihr Inhalt in standardisierter Form extrahiert.
Die interne Validität einzelner Studien wurden anhand eines Fragenkataloges geprüft und
dabei das Risiko von systematischen Fehlern nach einem dreistufigen Schema (hoch,
moderat, niedrig) bewertet.
Es lassen sich folgende Ergebnisse und daraus resultierende Schlussfolgerungen
zusammenfassen:
1. Folgende Gründe wurden für die Uneinheitlichkeit in vorliegenden Referenzwerten zur
Nährstoffzufuhr für Säuglinge als Hauptfaktoren identifiziert: Der Mikronährstoffbedarf bei
Säuglingen wird auf Körpergewicht oder Energieaufnahme basierend in Referenzwerte für
die Mikronährstoffzufuhr umgewandelt. Allerdings sind oft weder die verwendeten
normativen Daten, noch die angewandten Extrapolationsmethoden erklärt. Die
Etablierung verschiedener Altersgruppen, und damit verbundene spezielle Referenzwerte
innerhalb der ersten 12 Lebensmonate sind nicht begründet, mit Ausnahme des
Übergangs von Milch zur Beikost.
Die Vielfalt der verwendeten normativen Daten zur Extrapolierung von Referenzwerten ist
die Hauptquelle der Schwankung zwischen Referenzwerten für stillende Frauen in den
verschiedenen europäischen Ländern.
Die unzureichenden erhältlichen Informationen bezüglich der Entwicklung von
Referenzwerten für Säuglinge und stillende Frauen in den europäischen Ländern machen
einer erheblichen Mangel an Transparenz deutlich.
2. Bei der systematischen Literaturübersicht entsprachen 13 Studien den Selektionskriterien
der Zielgröße Neuroentwicklung und 7 der Zielgröße Immunität. Die meisten Studien
hatten ein hohes oder moderates Risiko für systematische Fehler.
Aufgrund verschiedenartiger Ergebnisse hinsichtlich der Zielgröße Neuroentwicklung war
keine klare Tendenz ersichtlich. Insgesamt jedoch zeigten die Studien eine geringe
positive Wirkung der Eisensupplementierung auf die kognitive und auch auf die
psychomotorische Entwicklung, besonders nach langfristigen Supplementierungsperioden
(> 2 Monate) und vor allem in anämischen Säuglingen und Kindern.
Ein Vergleich von Studien, die die Zielgröße Immunität betrachten, war aufgrund der
hohen Heterogenität der Zielparameter nicht möglich. Zurzeit ist die verfügbare Datenlage
aus RCTs zu unvollständig, um begründete Aussagen über die Wirkung von Eisen auf die
Immunität bei Säuglingen, Kindern und Jugendliche zu treffen.
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Abstract
This paper presents a review of the current knowledge regarding the macro- and micronutrient requirements of
infants and discusses issues related to these requirements during the first year of life. The paper also reviews the
current reference values used in European countries and the methodological approaches used to derive them by
a sample of seven European and international authoritative committees from which background scientific
reports are available. Throughout the paper, the main issues contributing to disparities in micronutrient refer-
ence values for infants are highlighted. The identification of these issues in relation to the specific physiological
aspects of infants  is important for informing future initiatives aimed  at providing standardized approaches to
overcome variability of micronutrient reference values across Europe for this age group.
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Background
Different countries and committees have set micro-
nutrient reference values for infancy, i.e. up to 1 year
of age. These values vary considerably across Europe.
The variability is caused by various factors, e.g.
disparities exist between underlying concepts, the ter-
minologies used and the methodologies and assump-
tions that have been made in the definition
of micronutrient requirements and derivation of
reference values for intake (Doets et al. 2008). Infants
are considered a vulnerable group because they have
a relatively high requirement of nutrients per unit
body weight during a sensitive period of rapid growth
and development. The aim of the present paper is to
review specific aspects of healthy term infants in rela-
tion to micronutrient requirements in early and late
infancy, and to critically evaluate the approaches used
to determine those requirements and derived refer-
ence values for nutrient intake.
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1. Nutritional requirements of
infants, methodological approaches
used for establishing requirements
and derived reference values
Infancy  is characterized by rapid growth and devel-
opment. Both are determined by genetic and environ-
mental factors. An important environmental factor is
nutrition, because an inadequate diet can compro-
mise growth and the full utilization of an individual’s
genetic potential (Reyes-Posso 2008). Nutrition is
important   throughout childhood, but especially
during the first 2 years of life, as the growth rate
during this period is high and less dependent on
growth hormones than in later periods of childhood.
The rapid rates of growth and development of infants
impose unique nutritional needs upon their already
high maintenance needs (Heird 1996). The quantity
and quality of nutrient supply during early life modu-
lates the differentiation of tissues and organs and has
short- and long-term consequences for health
(Koletzko 2008).
The preferred form of nutrition for healthy infants
is breastfeeding (Agostoni et al. 2009). Current global
recommendations, derived from a technical expert
committee report commissioned by the World Health
Organization (WHO) (Kramer & Kakuma 2002), are
that infants should be exclusively breastfed for the
first 6 months of life with the introduction of comple-
mentary foods thereafter and continued breastfeed-
ing for the first 2 years of the infant’s life (WHO
2003b). This report concluded that infants who were
exclusively breastfed for 6 months did not differ in
growth from those exclusively breastfed for 4 months
and experienced less morbidity from gastrointestinal
infection. Recent expert committee reports in Europe
and in the USA concluded that complementary
feeding, in addition to continued breastfeeding,
should be introduced not before 17 weeks and not
later than 26 weeks of age (Agostoni et al. 2008; Greer
et al. 2008). The comparative benefits of exclusive
breastfeeding for six months compared with exclusive
breastfeeding for between 4 and 6 months, particu-
larly in infants living in industrialized countries,
however, has been challenged (Fewtrell et al. 2007). In
Kramer & Kakuma’s paper (2002), only two of 20 the
studies included in the review were randomized inter-
vention trials of different exclusive breastfeeding
recommendations, and both were conducted in non-
industrialized countries (Cohen et al. 1994; Dewey
et al. 1999). Due, in no small part, to clear ethical and
feasibility issues of conducting such trials, the overrid-
ing majority of studies in the review were observa-
tional and therefore   vulnerable to considerable
residual confounding and bias. Indeed, other system-
atic reviews have suggested that breast milk may not
meet the full requirements for energy and certain
micronutrients of 6-month-old infants (Butte 2002;
Reilly et al. 2005). Clearly, there is an urgent need for
more work in this area.
Despite the multiple benefits of breastfeeding, a
significant proportion of mothers of healthy term
infants in many industrialized countries chose to
formula feed their infants. There is a lack of guidance
regarding the appropriate timing of the introduction
of complementary foods to formula fed infants
because there is virtually no data available to form
evidence-based recommendations. It has been argued
Key messages
•  Infancy is characterized by growth and development, which impose unique nutritional needs upon the already
high maintenance needs of infants.
•  Primary data from quality studies linked to functionally relevant outcomes are needed in infants in order to
improve the current knowledge on nutritional requirements in this period of life.
•  Great disparities exist in established nutrient intake values for infants in Europe. This is mainly due to the
different methodological approaches used to define the nutritional requirements of infants. A lack of trans-
parency in the documentation of the decision making by the committees in charge hampers understanding
these differences.
•  Solid, up-to-date, transparent scientific basis will help committees tasked with setting reference values for
nutrients, defining requirements of infant formula, and defining feeding practice.
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that, as formula-fed infants receive higher amounts of
energy, protein, iron and zinc than breastfed infants,
they may not require solid foods until a later age
(Fewtrell et al. 2007). Despite this, across Europe,
complementary feeding is introduced earlier in
formula fed than in breastfed infants (Schiess et al.
2010). It has  been hypothesized that an early intro-
duction of complementary foods to formula fed
infants might increase the risk of later overweight and
obesity in children and adults. There is evidence to
suggest that formula feeding is associated with a more
rapid weight   gain in early infancy (Dewey 2001;
Baker et al. 2004) and with an increased risk for
obesity in childhood and adolescence (Gillman et al.
2001; von Kries et al. 2001; Arenz et al. 2004; Koletzko
et al. 2009b). Higher intakes of protein and energy
with infant formula compared with breast milk may
favour rapid weight gain, adipogenic development of
adipocytes   and the accumulation of fat (Koletzko
et al. 2009a). This could lead to increased likelihood of
later overweight, but it is as yet unclear whether an
earlier introduction of complementary foods plays a
relevant role.
1.1 Concepts and use of nutrient intake values
The European Micronutrient Recommendations
Aligned (EURRECA) Network of Excellence works
similarly towards a general framework including har-
monized approaches, methods and key terms to be
used for the development of micronutrient reference
values (Doets et al. 2008). The United Nations Univer-
sity (UNU), in collaboration with the Food and
Agricultural Organisation (FAO), World Health
Organisation (WHO) and  the United Nations Chil-
dren’s Emergency Fund (UNICEF), has previously
proposed an international harmonization of nutrient
based dietary standards (King & Garza 2007). The
term Nutrient Intake Values (NIVs), conceived by
UNU, FAO, WHO and UNICEF, encompass all
nutrient-based dietary standards derived from
primary data and provide estimates on appropriate
dietary substrate supply for populations of healthy
people (King & Garza 2007). NIVs are used for assess-
ing the adequacy of nutrient intakes and for planning
diets of groups and individuals. They are also applied
to  a number of aspects of food  and nutrition policy
such as regulatory issues and trade, labelling, planning
programmes for alleviating public health nutrition
problems, food fortification and dietary guidance
(Aggett et al. 1997). NIVs are based on physiological
requirements, which are defined by the European
Society of Paediatric Gastroenterology, Hepatology
and Nutrition (ESPGHAN) as the amounts and
chemical forms of nutrients needed systematically to
maintain normal   health and development, without
disturbance of the metabolism of any other nutrient
and without extreme homeostatic processes and
excessive depletion or surplus of bodily reports
(Aggett et al. 1997). The nutrient requirements of indi-
viduals vary markedly, and NIVs do not refer to indi-
viduals, but to populations that are defined by age,
gender and in some cases additional characteristics
relevant for nutrient needs. Existing NIVs for infants
are shown and compared in section 2.
The UNU Working Group has defined the following
NIVs: average nutrient requirement (ANR), indi-
vidual nutrient level (INL) and upper nutrient level
(UNL). ANR is the estimated average or median
requirement of a specific nutrient in a population,
derived from a statistical distribution of requirement
criterion and for a particular age and sex specific group
based on a specific biological endpoint or biochemical
measure (King & Garza 2007). It is assumed that
individual requirements follow a statistical distribu-
tion (symmetrical bell-shaped curve). INL is the indi-
vidual nutrient level and INL97 is the nutrient intake
considered adequate to meet   the known nutrient
needs of practically all healthy individuals in a particu-
lar age and sex-specific group (King & Garza 2007).
Equivalent terms  are population reference intakes
and recommended dietary allowance. This value, set at
a level of intake that meets the needs of the majority of
the population (mean + 2SD), is generally  used as the
target for provision of essential nutrients to popula-
tions and as the reference point for nutrient labelling
of foods.The exception is energy, for which the ANR is
used because the  use of INL97 or equivalents would
lead to overfeeding. UNL is the highest level of daily
nutrient intake that is likely to pose no risk of adverse
health effects for almost all individuals of a particular
life-stage group (King & Garza 2007).
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1.2 Methods used to estimate the nutritional
requirements of infants and derived NIVs
Indicators of function provide information to target
requirements for health protection and not just to
prevent clinical deficiencies. However, there are a
limited number of functionally relevant outcome
measures for infants that reflect the response to
dietary intake (IOM 2000b). The first months of life
pose particular challenges   with regards to clinical
research, and few quality studies have been per-
formed in this age group. The paucity of available
data for estimating nutrient requirements of infants
hampers the establishment of adequate NIVs (Pombo
et al. 2001). Usual intakes of presumably healthy
populations, factorial approaches and balance tech-
niques are the methods used most often to estimate
nutrient needs of infants. None are fully satisfactory
because they seldom adequately address the issue of
nutrient intake supporting long-term health and
optimal functional capacities rather than just avoiding
acute deficiency states (Butte 2002).
NIVs for infants during the first 6 months of life are
usually derived from estimated intakes of fully breast-
fed infants. For older infants (7–12 months), estimates
of intakes from both human milk and complementary
foods are used as a reference. However, the actual
intakes of breastfed infants  are difficult to determine
due to the variability of milk volume and composition
between women, as well as the changing composition
of the milk during the course of lactation, during the
day and even during a feeding. Moreover, the bio-
availability of substrates and their metabolism differ
between infants fed human milk, those fed infant
formula and infants given complementary feeds.
Therefore, the composition of human milk and the
nutrient  intake   of breastfed infants do not always
provide useful guidance for infants who are not exclu-
sively breastfed (Aggett et al. 1997).
Factorial approaches are  generally based on esti-
mates of maintenance needs, nutrient accretion that
accompanies growth, measures of digestibility and/or
absorption (bioavailability), and utilization efficiency.
The requirements for growth are derived from esti-
mates of body composition at different ages, from
which the nutrient accretion over time (increase in
the total body content of that nutrient from one age
to another) can be calculated, taking into account the
metabolic cost of accretion. However, very limited
direct analytical information on body composition is
available, which cannot    be reliably extrapolated
between age groups. Maintenance needs are derived
from estimates of losses related to cellular turnover
and unavoidable metabolic inefficiency. Data on
inevitable losses in newborns, toddlers and infants are
scant. Given that in adults such information is best
gained under circumstances of negligible intakes of
the nutrient of interest when homeostatic conserva-
tion is maximal, it is unlikely that such data could be
acquired ethically  in infants (Aggett et al. 1997).
Balance studies at known intakes provide informa-
tion about net whole retention and net intestinal
absorption or secretion and whole-body retention of
nutrients. These studies are difficult to perform in
infants, although some studies have been performed
in term and pre-term infants. One limitation is that
they tend to overestimate net retention and thus
underestimate requirements due to technical difficul-
ties in sampling. To extrapolate nutrient requirements
from balance studies, subjects should be in equilib-
rium at the intake of the nutrient in question, which is
difficult to determine in periods of fast growth. The
intake has to be manipulated so that it balances losses.
The length of the study period also depends on the
size of the body stores of the nutrient and the rate at
which the stores are mobilized (Prentice et al. 2004).
The interpretation of balance studies often relies
heavily on estimates derived  by factorial approaches,
that is, the appropriateness of retained quantities of
target nutrients is determined by comparison with
expected retention based on estimates derived by fac-
torial methods. Thus, estimates of growth velocity and
tissue composition are key to interpreting balance
results (Butte 2002). The use of isotopic labels of
endogenous or exogenous (dietary) pools of nutrients
can enable better characterization of the flux and pool
sizes underlying homeostasis. Thus, the balance-study
approach, with these refinements, is likely to remain a
key method in investigating requirements until new
methods become established (Aggett et al. 1997).
Extrapolation and interpolation methods are often
employed to derive NIVs for infants, especially from 7
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months of age. Values for nutrient needs are extrapo-
lated from one life stage to another using weighting
for body size, energy requirement and other meta-
bolic differences. These approaches have several limi-
tations, as outlined elsewhere (Atkinson & Koletzko
2007). The rationale for   the method chosen for
extrapolating NIVs should be completely transparent
and described in detail for each nutrient (Atkinson &
Koletzko 2007).
1.3 Nutrient requirements of infants for energy,
macro- and micronutrients
1.3.1 Energy and macronutrients requirements
Energy
During infancy, energy requirements are defined as
the amount of energy needed to balance total energy
expenditure at a desirable level  of physical activity,
and to support optimal growth and development con-
sistent with long-term health (FAO/WHO/UNU
2004). Energy requirements during growth and devel-
opment can be partitioned into components of basal
metabolism, thermogenesis, physical activity and
energy cost of growth (Butte 2005). The energy
needed for growth is estimated to be around 35% of
the total energy requirement in the first month of life,
and this requirement declines continuously to about
3% at 12 months, remaining low until the onset of the
pubertal growth spurt (Butte 2005).
Protein
The protein requirement of infants  can be defined as
the minimum intake that will allow nitrogen equilib-
rium at an appropriate body composition during
energy balance at moderate physical activity, plus the
needs associated with the deposition of tissues consis-
tent with good health (WHO/FAO/UNU 2007). The
nine essential amino acids (leucine, isoleucine, valine,
tryptophan, phenylalanine, methionine, threonine and
histidine) need to be obtained from the diet. The con-
ditionally essential   amino acids (arginine, cysteine,
glutamine, glycine, proline and tyrosine) are those that
the infant in unable to produce in sufficient amounts
and hence all or part of the daily needs for those amino
acids must be provided through the diet (Pencharz &
Elango 2008). The average protein content of human
milk is 11.7 g/L-1 (Pencharz & Elango 2008). Exclusive
breastfeeding meets the protein and amino acid
requirements during the first 4–6 months of life.
During the second 6 months of life, solid foods contrib-
ute a significant amount of protein to the infant diet.
The biological  value of a protein refers to its ability,
when it is the sole dietary source of protein, to support
protein synthesis and therefore body maintenance and
growth. On this scale, breast milk proteins and egg
have the highest value (1.0). All animal proteins (with
the exception of gelatin) are  complete, that is they
contain all the essential amino acids and are of high
biological value. Most vegetable proteins, except soya,
are incomplete because they offer an unbalanced
assortment of amino acids that cannot alone satisfy the
body’s needs (Michaelsen et al. 2000).
Lipids
Fats are the main source of energy for infants, and n-6
and n-3 long-chain polyunsaturated fatty acids
(LCPUFAs) are essential for normal growth and
development and maturation of numerous organ
systems, most importantly the brain and eye. More-
over, lipid-soluble vitamins   (A, D, E, K) require
dietary lipids  for absorption (Mena & Uauy 2008).
Exclusively breastfed infants receive a dietary fat
supply usually in the range of 40–55% of total dietary
energy intake (Michaelsen et al. 1990). The introduc-
tion of complementary feeding that is rich in carbohy-
drates may  reduce fat  intake to 30–40% of energy
intake. For infant formula a fat content in the range of
40–60% of total   energy content has been recom-
mended (Scientific Committee on Food 2003). This
corresponds to a fat content of 4 to 6 g/100 kcal as
established by the European Commission Directive
on Infant Formulae and Follow on Formulae (Euro-
pean Commission 2006). Human milk provides
linoleic acid (LA), alpha-linoleic acid (ALA), docosa-
hexaenoic acid (DHA), arachidonic acid (AA), and
other LCPUFAs to breastfed infants. The level of AA
is relatively constant on a worldwide basis whereas the
level of DHA is more variable and depends on mater-
nal diet and lifestyle (Koletzko et al. 2008). Recent
consensus recommendations support that pregnant
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and  lactating women should achieve a DHA intake
of at least 200 mg/d (Koletzko et al. 2007). The
ESPGHAN recommends the following content of
essential fatty acids in infant formula: 0.3–1.2 g/
100 kcal (2.7–10.8% total energy) of LA and 0.5–2.4 g/
100 kcal (0.54–2.59% total energy) of ALA, with a
minimum LA/ALA ratio of 5:1 and a maximum of
15:1 (Koletzko et al. 2005). The authors of a recent
review conclude that the available evidence supports
the addition of DHA to infant formula: the addition of
at least 0.2% of fatty acids as DHA appears necessary
for achieving a benefit on functional endpoints, but
DHA levels  should not exceed 0.5% of fatty acids
because systematic evaluation of higher levels of
intake have not been published (Koletzko et al. 2008).
Based on current knowledge, infant formula contents
of AA should be at least  those of added DHA, and
eicosapentaenoic acid (EPA)    should not exceed
levels of DHA (Koletzko et al. 2008).
Examples of reference values used in European
countries for average daily energy, protein, fat
and essential fatty acids intakes in populations of
healthy infants set by different European and inter-
national committees is presented for comparison in
Table 1.
Digestible and indigestible carbohydrates
Lactose is the main digestible carbohydrate in human
milk, providing about 40% of the energy content
(Koletzko et al. 2005). In addition to lactose, mature
breast milk contains a large variety of oligosaccharides
in concentrations of approximately 5–10 g/L-1 (Kunz
et al. 2000). Human milk oligosaccharides may prevent
bacterial adhesion by interfering with the docking of
bacteria on the intestinal cell surface and with the
expression of certain enzymes in the intestine required
for bacterial adhesion (Bode 2006). The total digest-
ible carbohydrate content of infant formula and
follow-on formula is set between 9 and 14 g/kcal, which
is based on the calculated glucose consumption of the
central nervous system (Scientific Committee on Food
2003; European Commission 2006). Non-digestible
carbohydrates such as fructooligosaccharides, galac-
tooligosaccharides, inulin, soy polysaccharide, resis-
tant  starch, and gums are added to dietary products,
enteral formulas and breast milk substitutes consumed
by infants. Additionally, some resistant starches and
non digestible carbohydrates are formed during pro-
cessing (Aggett et al. 2003). The overall benefits to
health of supplementing infant formula or infant solid
foods with fibre, inulin (probiotics) or prebiotic oli-
gosaccharides remain unclear (Agostoni et al. 2004;
Kien 2008).
1.3.2 Micronutrient requirements
Iron
During the first year of life, the body iron content
increases markedly. In healthy term infants, iron stores
at birth comprise most of the iron requirements during
the first 4–6 months. From the 4th month, the require-
ment for dietary iron increases to an estimated
0.78 mg/day due to the stepwise depletion of endog-
enous stores and rapid growth with an expansion of
blood volume and increased tissue and storage iron
(AAP 1999; Fisher et al. 2000; IOM 2000b). Iron defi-
ciency in humans is most prevalent in the late infancy
period, which is characterized by peak hippocampal
and cortical regional development, as well as myelo-
genesis, dendritogenesis and synaptogenesis in the
brain where iron availability may play a role (Lozoff &
Georgieff 2006). Although the iron content of breast
milk is low, its bioavailability is high and needs of
dietary iron are limited due to the large iron stores of
newborn infants born at term, therefore iron defi-
ciency at 6 months is uncommon in exclusively breast-
fed, term infants in industrialized countries (Yang et al.
2009). It has been shown that the same is true for
healthy full-term born infants fed exclusively an infant
formula with only 1.6 mg iron/L-1 (Hernell & Lönner-
dal 2002); despite this most modern infant formulae
are fortified with iron. A recent study has shown that
while   iron supplementation of breastfed infants
caused some preservation of the iron endowment, the
effect was modest and did not extend beyond the
period of supplementation (Ziegler et al. 2009). The
study was underpowered to investigate any adverse
affects of supplementation. However, other studies
have reported adverse effects of iron supplementation
in iron replete infants, for example on length growth
(Domellof 2007). Due  to the low prevalence of iron
PUBLICATION 1 27
Table 1. Comparison of reference values for average daily energy, protein, fat and essential fatty acids intakes by different countries and
committees in populations of healthy infants
Age Energy Protein Fat Essential fatty acids
Male/female Male/female Male/female n-6 n-3
DACH[1] Month
0–<4 0–1
kcal/d
500 / 450
g/d
12
% of energy
45–50
% of energy
4.0 0.5
1–2 700 / 700 10
2–4 10
4–<12 4–6 95 10 35–45 3.5 0.5
NNR[2] Month
6–12
MJ/d
10
% of energy % of energy % of energy
<6 0–1 1.3 / 1.4 – – – –
3 2.1 / 2.2
6–11 6 2.6 / 2.7 7–15 30–45 4 1
UK[3] Month
12 3.4 / 3.7
kcal/d g/d
0–<3 545 / 515 12.5 – –
4–<6 690 / 645 12.7 – –
7–<9 825 / 765 13.7 – –
USA/Canada[4]
10–<12
Month
920 / 865
kcal/d
14.9
g/d
–
g/d
–
g/d
0-<6 1 472 / 438 9.1 31 4.4 0.5
2 567 / 500
3 572 / 521
4 548 / 508
5 596 / 553
6 645 / 593
7-<12 7 668 / 608 11 30 4.6 0.5
8 710 / 643
9 746 / 678
10 793 / 717
WHO/FAO/UNU[5a, 5b] Month
11 817 / 742
kcal/d g/d % of energy
3–6 700 13
6–9 810 14 30–40
The Netherlands[6]
9–12
Month
950
MJ/[kg.d]
14
g/d % of energy g/day
0–2 0.39 9/8 45–50 0.64 –
3–5 0.35 10/9 45–50 0.64 –
6–11 0.35 10/10 40 0.15–0.2
[1]German Nutrition Society (DGE),Austrian Nutrition Society (OGE), Swiss Society for Nutrition Research (SGE), Swiss Nutrition Association
(SVE) (2000) Referenzwerte für die Nahrstoffzufuhr/Reference Values for Nutrient Intake, 1st edition, 3 vollständig durchgesehener und
korrigierter Nachdruck 2008. Frankfurt am Main: Umschau/Braus.
[2]Nordic Council of Ministers (2004) Nordic Nutrition Recommendations 2004, 4th edition: Integrating nutrition and physical activity.
Copenhagen.
[3]Department of Health (1991) Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report on Health and Social
Subjects 41. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London: HMSO.
[4]Food and Nutrition Board, Institute of Medicine (2005) Dietary Reference Intakes for Energy, Carbohydrate, Fibre, Fat, Fatty
Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). National Academy Press: Washington DC.
[5a]Joint FAO/WHO/UNU Expert Consultation on Human Energy Requirements (2004) Human energy requirements: report of a Joint
FAO/WHO/UNU Expert Consultation. (FAO Food and Nutrition Technical Report Series, no. 1) Rome.
[5b]Joint WHO/FAO/UNU Expert Consultation on Protein and Amino Acid Requirements in Human Nutrition (2007) Protein and amino acid
requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. (WHO technical report series; no. 935) Geneva.
[6]Health Council of the Netherlands (2001) Dietary Reference Intakes: energy, proteins, fats and digestible carbohydrates. The Hague: Health
Council of the Netherlands; publication no. 2001/19R (corrected edition: June 2002).
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deficiency in infants in affluent populations, universal
iron supplementation appears unjustified. The
ESPGHAN Committee on Nutrition recommends an
iron content ranging from 0.3 to 1.3 mg/100 kcal in
infant formulae (Koletzko et al. 2005). Substantial evi-
dence indicates that some indictors of iron status, par-
ticularly ferritin and haemoglobin concentrations, are
lower in boys than in girls (Domellof et al. 2002). It has
been suggested that boys may have lower body iron
stores at birth or higher intestinal iron losses than girls
(Yang et al. 2009). Other possible explanations for the
reported gender difference could be due to genetic or
hormonal factors, but further research is warranted
(Domellof et al. 2002).
Zinc
Both iron and zinc  are critical for normal growth,
haematopoiesis, immune function and neurologic
development during infancy. The young infant has a
relatively high zinc requirement to support his very
rapid growth. Zinc and protein intakes have been
shown to be predictors of head growth (Krebs 2000,
2007). Some studies show that  zinc intakes are lower
than recommendations established for this age group,
but it has been proposed that some current recom-
mendations are higher than actual needs (García-
Ramos Estarriol et al. 2000).
About 40% of the breast milk zinc content is
absorbed, which is considered to be sufficient to meet
the requirements of zinc in the first 6 months. To date
there is no marker of zinc deficiency that is sensitive
and specific. This explains why there is considerable
variability in the requirements and recommendations
of various international agencies. A committee of
experts convened by the WHO proposed  that the
recommendations should be based on the metabolic
requirements of each age, including a factor that rep-
resents the interference of phytates in the absorption.
These recommendations (lower limits of consump-
tion of zinc) were adjusted  to diets with low bioavail-
ability of zinc (phytate content >15 mg/day), median
bioavailability (10–15 mg phytate/day) and high bio-
availability (<15 mg phytate/day) (Gil Hernandez
et al. 2006). It has  been concluded that complemen-
tary feeding   should provide 84–89% of the zinc
requirements between 6 and 24 months of life
(Dewey 2001). Animal products are the best source of
zinc, both in their content and bioavailability.
Calcium
Calcium is the most abundant mineral in the human
body (Perez-Lopez 2007). Over 99% of total body
calcium is found in teeth and bones. The remainder is
present in blood, extracellular fluid, muscle and other
tissues, where it  plays a  role in mediating vascular
contraction and vasodilatation,  muscle contraction,
nerve transmission and glandular secretion. The
calcium content of infant formulae is often greater
than breast milk to account for a lower fractional
calcium absorption in order to achieve a comparable
calcium retention (IOM 1997).
Iodine
Iodine is a trace element required for the production
of the thyroid hormones, triiodothyronine and thy-
roxine. These hormones play a vital role in the early
growth and development of most organs, especially
the brain (Perez-Lopez 2007). Monitoring of iodine
status during infancy is difficult as there are no estab-
lished reference criteria for urinary iodine concentra-
tion for this age group (Zimmermann 2007). The
iodine content of breast milk and the infant’s small
iodine pool in the thyroid turns over very rapidly and
is highly sensitive to variations in dietary iodine
intake. Studies from France, Germany, Belgium,
Sweden, Spain, Italy, Denmark, Thailand and Zaire
have shown that breast milk concentrations of iodine
are lower than recommended levels, suggesting a less
than optimal maternal and infant iodine nutrition in
many countries (Azizi & Smyth 2009).
Sodium
Infants are less efficient  in excreting excess dietary
sodium   than   adults (Michaelsen et al. 2000). High
sodium intakes during infancy carry both short- and
long-term risks. Short-term effects include hyper-
natraemia, tissue dehydration, renal dysfunction and
increased blood pressure. A possible life threatening
acute complication is severe hypernatriaemic dehy-
dration, which occurs at high sodium intakes without
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sufficiently rehydrating a child to compensate for past
and ongoing losses, and can lead to renal insufficiency
and failure to excrete sodium (Fomon 1993). The role
of salt intake during complementary feeding has not
been extensively explored. Investigations demon-
strating that an  excess  of dietary sodium may raise
blood pressure in newborns and young infants have
suggested that infancy may be a period of greater salt
sensitivity than later in life (Agostoni et al. 2008).
There is evidence that early life factors are important
determinants of adult blood pressure (Lawlor &
Smith 2005). The long-term effects of high salt intake
in infancy on blood pressure are possible, but so far
not proven (Brion et al. 2007).
Copper
Copper concentrations in human milk decrease during
the course of lactation and appear to be unrelated to
maternal serum levels (Dorea 2000). Based on the
copper concentration of human milk, the Institute of
Medicine (IOM) estimated that intakes of 200 mg/day
were adequate for the first 6 months of life increasing
to 220 mg/day for the second 6 months (IOM 2000b).
For formula fed infants, the United States Food and
Drugs Administration (FDA), Codex Alimentarius
and the American Academy of Pediatrics (AAP) rec-
ommend a minimum level of an artificial formula for
copper of 0.6 mg/kcal, whereas the ESPGHAN Com-
mittee on Nutrition recommends 35 to 80 mg/100 kcal
(Koletzko et al. 2005). There has been concern about
the potential risks of excess copper supply in infants
fed powered infant formula mixed with tap water with
a high copper content. Copper in drinking water con-
tributes 0.1–1 mg/day in most situations, but water
obtained from unprotected copper pipes or fittings can
considerably increase total daily copper exposure
(WHO 2003a). The WHO has proposed that a copper
content of drinking water not exceeding 2 mg/L-1
would provide an adequate margin of safety in popu-
lations with normal copper homeostasis (WHO
2003a); whereas it has been proposed that infants fed
powdered formula prepared with tap water containing
>2 mg/L-1 copper may pose a risk for liver damage
particularly in young infants (Uauy et al. 2008).A con-
trolled study of 100 healthy infants consuming water
with 2 mg of copper per litre from 3 months onwards
did not show biochemical or clinical evidence of health
problems (Olivares et al. 1998), but the intervention
was only started after the age considered most sensi-
tive for copper toxicity. An epidemiological survey in
Germany did  not demonstrate a link between high
copper exposure from water and evidence of liver
abnormalities in infants, but there was no systematic
health assessment for markers of copper toxicity in the
infant population studied (Zietz et al. 2003).
Vitamin A is a group of compounds, the precursor
of which is trans-retinol. Vitamin A is essential for
growth and differentiation of a number of cells and
tissues. It is one of the most critical vitamins during
the breastfeeding period because it has an important
role in the healthy development of the newborn, with
lung development and maturation being particularly
important. Insufficient  intake of vitamin A by infants
may have serious consequences, especially regarding
susceptibility to infections, the development and func-
tion of respiratory organs and the integrity of mucous
membranes (Strobel et al. 2007). Vitamin A deficien-
cies are uncommon in breastfed infants in Europe,
although retinol and retinyl esters content in breast
milk varies widely depending on maternal intake.
b-carotene is found in plants and is considered a pro-
vitamin of  vitamin A because humans are able to
convert it into retinol. However, its bioequivalence to
retinol in infants is not known. For this reason, the
Scientific Committee on Food of the European Com-
mission advised that   vitamin A activity in infant
formula should be provided by retinol or retinyl
esters, while any carotene content should not be
included in the calculation and declaration of vitamin
A activity (SCF 2003).
Vitamin D is required to maintain adequate calcium
metabolism and bone health at all ages. Many coun-
tries recommend vitamin D supplementation during
infancy to avoid rickets resulting from its low content
in human milk (Molgaard & Michaelsen 2003). For
prevention of rickets, the Committee on Nutrition of
the AAP recommends supplementing breastfed
infants, whether consuming formula or not, with
400 IU (10 mg) of vitamin D per day from birth
(Wagner & Greer 2008). In addition to dietary supply,
the infant’s vitamin D status is also modified by sun-
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light exposure and hence the season of the year and the
geographical latitude. Dark-skinned children or chil-
dren whose clothing obscures the skin may be at great-
est risk of vitamin D deficiency. Ziegler et al. (2006)
reported that 10% of breastfed infants living in Iowa
(41 degrees N) were deficient in vitamin D as deter-
mined by low serum 25-OH-D levels; most were dark-
skinned (Ziegler et al. 2006).  Sunlight exposure is
critical for vitamin D  synthesis because cutaneous
biosynthesis upon exposure of skin to ultraviolet B
light is the major source of vitamin D for most people,
which influences vitamin D status and calcium absorp-
tion. Thus, there is an increased reliance on dietary
sources during winter months to help maintain
adequate vitamin D status (Cashman 2007; Kimlin
2008).
Vitamin C
The biological functions of vitamin C are based on its
ability to provide reducing equivalents for a variety of
biochemical reactions (IOM 2000a). Ascorbic acid is
important in facilitating iron absorption and a good
ascorbic acid status in the newborn is important for
collagen synthesis and may contribute to protecting
cells against oxidative insults (Jain et al. 2008). Breast-
fed infants of well nourished mothers do not require
vitamin C supplementation.
Vitamin E
This vitamin serves as a non-specific chain-breaking
antioxidant and protects cell membranes in the retina
and lungs against oxidant-induced injury (IOM
2000a). Breast milk concentrations of tocopherol
(~3 IU/100 kcal) appear adequate for meeting infant
requirements and particularly high levels are found in
colostrum. A study in the USA observed that infants
and children had low intakes of vitamin E compared
with the requirements established by the IOM (IOM
2000a), but there is some concern that those reference
values may be too high (Briefel et al. 2006).
Folate and cobalamin are necessary cofactors in the
synthesis of RNA and DNA, and cobalamin is
required for maintaining the nervous system. Both
vitamins are therefore critical to the rapid growth and
development during the early years of life (Hay et al.
2008). Reports of severe neurodevelopmental
damage and long-term neurologic sequelae due to
infantile cobalamin deficiency demonstrate the
importance of adequate cobalamin status during the
first months of life (von Schenck et al. 1997; Bjorke-
Monsen et al. 2008). However, reference values for
indices of cobalamin and folate status in infants are
lacking (Hay et al. 2008).
Several factors  may affect dietary intake of micro-
nutrients such as the composition of foods (e.g. iron
and calcium absorption depends on vitamin C and
vitamin D intakes, respectively) (Sandstrom 2001;
Cashman 2007) and the iodine concentration in the
soil that is determined by geographical location
(Aston & Brazier 1979).
Nutritional status  of infants depends on micronu-
trient supply with human milk that is modified by
maternal micronutrient intake and lifestyle, such  us
tobacco smoking, alcohol intake or drug consump-
tion. Moreover, micronutrient content and bioavail-
ability of infant formula and complementary foods
and variability of nutrient absorption are of impor-
tance (IOM 2000a).
2. Current European nutrient intake
values for infants
Previous EURRECA research activities collated and
compared current micronutrient reference values
from 35 countries and committees, by means of a
questionnaire and background documents (Doets
et al. 2008). There follows a summary of the specific
characteristics that concern the infant population
group, together with a comparison of reference values
used in European countries and discussion of the
methodological approaches to set them.
2.1 Characteristics of the infant population
group in currently used micronutrient
intake values
The definition  of age groups within infancy, each con-
sidered as relatively homogenous with regard to
nutrient requirement, differ between countries and
committees that have set reference values for intake.
This may be due to differences in reasoning in defin-
ing population groups, but in most publications these
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arguments are not clearly described (Doets et al.
2008). Most European countries have set reference
values for one or two age groups during infancy: 13 of
the 30 countries investigated by Doets and colleagues
and the WHO/FAO defined two age groups, while 12
countries and the European   Commission (EC)
defined only one age group. Four countries defined
four different age groups, and one country, the
Russian Federation, set three age groups. Serbia did
not set reference values for infants under the age of 1
year. The five Nordic countries (Denmark, Finland,
Iceland, Norway and Sweden), Croatia, Estonia, Italy
and the EC, do not give values for infants under 6
months. France did not set reference values for min-
erals  under 1 year of age, but they did for vitamins.
None of the countries or committees set different
values for male and female infants.
Specific subpopulation groups   within the infant
group are specified for particular micronutrients by
some countries. Groups recognized are bottle and
formula fed infants, respectively (the Netherlands:
calcium, phosphorus, zinc and vitamin B6; WHO/
FAO: zinc and magnesium), and cows’ milk fed
infants (WHO/FAO: calcium).
The infant population group  is one of the popula-
tions recognized as a ‘vulnerable’ group (defined as a
population group in a healthy population having a
higher nutrient requirement) by 8 of the 35 countries
and committees questioned in the scoping exercise
for collecting reference values (Doets et al. 2008). The
most commonly cited micronutrients thought to be
related to infant vulnerability were vitamin D (in
three countries), vitamin A (n = 2), iodine (n = 2),
copper (n = 2) and iron (n = 2).
For the purposes of EURRECA, a list of terms and
definitions  that are relevant to the infancy period  and
to infant feeding have been agreed for use within the
network (Table 2).
2.2 Comparison of nutrient intake values
for infants
Micronutrient reference values for infants vary con-
siderably across Europe; for some micronutrients
there is a great difference between the highest and the
lowest values. Table 3a and b show the differences
between reference values used  in Europe that have
been set by the different European countries and
European and international committees for each
micronutrient at 3 and 9 months of age (lowest and
highest values for each micronutrient, mean value,
25th and 75th percentile). As reference values are
expressed as single values, multiple values, ranges and
so on, Doets and colleagues defined standardization
procedures to enable comparison (Doets et al. 2008).
Table 4a–d give an overview of the level of refer-
ence values set by each country/committee for vita-
mins, minerals and trace elements at two points of
time (3 and 9 months), defined as ‘high level’ when
they exceed the 75th percentile or ‘low level’ when
they fall below the 25th percentile.
Twenty-two countries, WHO/FAO and the EC have
their own background reports on the setting of nutri-
ent reference values; 13 countries based their refer-
ence values on those of other countries or
organizations; Germany, Austria and Switzerland
(DACH) and the Nordic countries cooperated in
setting reference values. The Nordic countries, the
DACH countries, France, Latvia, the Netherlands and
the United Kingdom, WHO/FAO and the EC, defined
their own reference values (Doets et al. 2008). Table 5
gives an overview of the European countries and
international working groups with published micro-
nutrient reference values used in Europe. From those
countries and committees setting their own reference
values, only a small number of documents provided
detailed information of  the evaluation  of evidence
supporting the reference values (United Kingdom
1991; EC 1993; DACH 2000; the Netherlands 1992,
2000 and 2003; France 2001; NNR 2004; WHO/FAO
2004). We will solely refer to these documents when
examining the methodological approaches for setting
their micronutrient reference values in detail (see
tables in section 2.2.1 to 2.2.4).
2.2.1 Water soluble vitamins (Table 6)
2.2.2 Fat soluble vitamins (Table 7)
2.2.3 Minerals (Table 8)
2.2.4 Trace elements (Table 9)
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Table 2. List of terms and definitions related to the infant population group and adopted by EURRECA Research Activity ‘infantnutrition’
Term Definition
Infant A person in the first year of life.
The first 12 months of life have been defined as an age group to set reference values by national and
international committees.Within this age group, reference values are set for one to four different age
subgroups. Most European countries defined one or two age subgroups.
For the purposes of EURRECA, the infant group is defined from birth up to 12 months of
age. Young infant An infant up to the 6th month of life (completed 180 days).
Older infant An infant from about the 6th month of life up to 1 year of age.
Newborn An infant from birth to 28 completed days.
The term newborn includes premature infants, post-mature infants and full term newborns.[1]
Pre-term birth Delivery before 37 completed weeks of gestation.[1]
Full-term Infant born between 37 completed weeks of gestation and less than 42 weeks.
Post-mature neonate Infant born after 42 weeks gestation.
Gestational age Time elapsed between the first day of the last menstrual period and the day of delivery. Measured
in completed weeks. [Note: If pregnancy was achieved using assisted reproductive technology, is
calculated by adding 2 weeks to conceptional age (time elapsed after conception)].[2]
Chronological age Time elapsed since birth. Measured in days, weeks, months or years.[2]
Post-menstrual age Gestational age + chronological age. Measured in days, weeks, months or years.[2]
Corrected age (similar term: adjusted age) Chronological age reduced by the number of weeks born before 40 weeks of gestation. Measured in
weeks or months used for preterm children until 3 years old.[2]
Toddler Young child who is of the age of learning to walk between infancy and childhood. Toddling usually
begins between age 12 and 24 months
Low birthweight (LBW) infant A neonate weighing less than 2500 g at birth (up to and including 2499 g), irrespective the
gestational age.[1]
Very low birthweight (VLBW) infant A neonate weighing less than 1500 g at birth.[1]
Extremely low birthweight (EXLW) A neonate weighing less than 1000 g at birth.[1]
Small for gestational age (SGA) infant Neonates with birthweight and/or length at least 2 standard deviations (SDs) below the mean
for gestational age ( -2 SD) based on the data derived from a reference population.[3]
Exclusive breast-feeding Exclusive breast-feeding implies that the infant receives only breast milk (including milk expressed or
from a wet nurse) and no other liquids or solids except for Oral Rehydration Solution (ORS) drops
or syrups consisting of vitamins, mineral supplements, or medicines.[4]
Predominant breastfeeding Predominant breastfeeding implies that breast milk (including milk expressed or from a wet nurse) is the
predominant source of nourishment, in combination with the supply of certain liquids (water and
water-based drinks, fruit juice) ritual fluids and ORS, drops or syrups (vitamins, mineral, medicines).[4]
Full breastfeeding Exclusive breastfeeding and predominant breastfeeding together.[5]
Breastfeeding Breastfeeding implies that the infant receives breast milk (including milk expressed or from a wet nurse)
and can also receive any food or liquid including non-human milk and formula.[4]
No breastfeeding The infant receives no breast milk.[5]
Complementary feeding (similar terms:
weaning, weaning
foods, Beikost)
The term ‘complementary feeding’ should embrace all solid and liquid foods other than breast milk
or infant formula and follow-on formula.[6]
Bottle-feeding Any liquid (including breast milk) or semi-solid food from a bottle with nipple/teat.[4]
Infant formulae Foodstuffs intended for particular nutritional use by infants during the first months of life and satisfying
by themselves the nutritional requirements of such infants until the introduction of appropriate
complementary feeding.[7]
Follow-on formulae Foodstuffs intended for particular nutritional use by infants when appropriate complementaryfeeding is
introduced and constituting the principal liquid element in a progressively diversified diet of such
infants.[7]
Breast milk substitutes Any food being marketed or otherwise presented as a partial or total replacement for breast milk,
whether or not suitable for that purpose.[8]
[1]WHOSIS (WHO statistical information system).
[2]American Academy of Pediatrics. Age Terminology During the Perinatal Period. Pediatrics 2004;114:1362–1364.
[3]International Small for Gestational Age Advisory Board consensus. Development conference statement: management of short children born small for gestational
age, April 24–October 1, 2001. Pediatrics. 2003 June;111(6 Pt 1):1253–61.
[4]Indicators for assessing infant and young child feeding practices: conclusions of a consensus meeting held 6–8 November 2007 in Washington D.C., USA. WHO
2008.
[5]Indicators for assessing breastfeeding practices. Report of an informal meeting in June 1991, Geneva. World Health Organization, Geneva.
[6]Agostoni et al. Complementary Feeding: A Commentary by the ESPGHAN Committee on Nutrition Journal of Pediatric Gastroenterology and Nutrition
2008,
46:99–110.
[7]Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999/21/EC.
[8]International Code of Marketing of Breast-milk Substitutes. World Health Organization Geneva, 1981.
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Thiamin (mg) 0.2 0.6 0.4 0.3 0.4
Rivoflavin (mg) 0.4 0.7 0.4 0.4 0.5
Niacin (mg) 2 8 5 4 6
Vitamin B12 (mg) 0.3 1.5 0.5 0.5 0.5
Folate (mg) 32 80 50 50 66
Vitamin C (mg) 20 55 35 30 40
Vitamin B6 (mg) 0.2 0.6 0.4 0.3 0.6
Vitamin A (mg) 300 600 388 350 400
Vitamin D (mg) 5 22.5 10 7 10
Vitamin E (mg) 2.7 6 4 3 4
Calcium (mg) 270 800 540 438 600
Phosphorus (mg) 200 500 400 300 500
Potassium (mg) 425 1110 750 700 800
Sodium (mg) 180 850 370 320 500
Magnesium (mg) 48 100 70 60 75
Iodine (mg) 40 135 50 50 63
Iron (mg) 6 15 9 7.8 10
Zinc (mg) 2 5 4.5 3.8 5
Selenium (mg) 8 40 15 10 19.3
Copper (mg) 0.2 1.5 0.4 0.3 0.7
Table 3. Comparison of micronutrient recommendations for infants at 3 and 9 months of age
Micronutrient (Unit) Lowest reference value Highest reference value Median P25 P75‡
a. Comparison of micronutrient recommendations for infants at 3 months of age
Thiamin (mg) 0.2 0.5 0.3 0.2 0.3
Rivoflavin (mg) 0.3 0.6 0.4 0.4 0.4
Niacin (mg) 2 8 4 2.3 5
Vitamin B12 (mg) 0.3 0.5 0.4 0.3 0.5
Folate (mg) 24 80 50 40 64
Vitamin C (mg) 25 50 35 29 40
Vitamin B6 (mg) 0.1 0.5 0.3 0.2 0.3
Vitamin A (mg) 350 500 400 375 435
Vitamin D (mg) 5 22.5 10 6.3 10
Vitamin E (mg) 2.7 6 3 3 4
Calcium (mg) 210 800 400 360 500
Phosphorus (mg) 100 400 300 141 300
Potassium (mg) 233 800 600 400 800
Sodium (mg) 100 638 210 200 250
Magnesium (mg) 24 70 50 39 55
Iodine (mg) 15 110 40 40 50
Iron (mg) 0.3 12.5 5 1.7 7
Zinc (mg) 1 5 3,5 2 4
Selenium (mg) 6 25 10 10 10
Copper (mg) 0.2 1.5 0.4 0.2 0.5
b. Comparison of micronutrient recommendations for infants at 9 months of age
25th percentile; ‡75th percentile.
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Year Ref. Vitamin C Vitamin B6 Vitamin A Vitamin D Vitamin E
3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months
Table 4. Overview of the level of reference values between countries for vitamins, minerals and trace elements
Country
a. Overview of the level of reference values between countries for vitamins
Albania 2005 [1] High High Low Low High
EC 1993 [2] – Low – – – High – –
Croatia 2004 [3] – – – – –
the Netherlands 1992 [4a] High Low Low – –
2000 [4b]
2003 [4c]
2008# [4d]
Ireland 1999 [5] Low Low Low – –
DACH 2000 [6] High High High High
Belgium 2006 [7] High Low High High – –
Romania 1990 [8] High High High – –
Latvia 2001 [9]
France 2001 [10] High High Low High High
The former Yugoslav Republic
of Macedonia
2001 [11]
Slovakia 1997 [12] High High High High
Lithuania 1999 [13]
Bulgaria 2005 [14] Low Low Low Low Low
Nordic countries 2005 [15] – Low – – Low – –
United Kingdom 1991 [16] Low Low Low – –
Bosnia and Herzegovina 2005 [17] Low Low Low Low Low Low
Spain 2007 [18] High High High High High High
Serbia 1994 [19] – – – – – – – – –
Italy 1996 [20] – – – – High – –
Russian Federation 1991 [21] High
Estonia 2006 [22] – – – Low – –
WHO/FAO 2004 [23] Low Low Low Low Low
Poland 1996 [24] High High High
Iceland 2006 [25] – Low – – Low – –
Hungary 2005 [26] High High
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b. Overview of the level of recommendations between countries for vitamins
Thiamin Riboflavin Niacin Vitamin B12 Folate
3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months
Albania 2005 [1] Low High High
EC 1993 [2] – – – – –
Croatia 2004 [3] – – – – – Low
the Netherlands 2000 [4b] Low Low
2003 [4c]
Ireland 1999 [5] – –
DACH 2000 [6] Low High High
Belgium 2006 [7] High High
Romania 1990 [8] High High High – – – –
Latvia 2001 [9] High High Low Low
France 2001 [10] Low High High
The former Yugoslav Republic
of Macedonia
2001 [11] High Low Low
Slovakia 1997 [12] High High
Lithuania 1999 [13] High High High High Low Low
Bulgaria 2005 [14] Low High High
Nordic countries 2005 [15] – – – – –
United Kingdom 1991 [16]
Bosnia and Herzegovina 2005 [17] Low High High
Spain progr [18] High Low
Serbia 1994 [19] – – – – – – – – –
Italy 1996 [20] – – – –
Russian Federation 1991 [21] High High High
Estonia 2006 [22] – – – – –
WHO/FAO 2004 [23] Low High High High
Poland 1996 [24] High High High High High High Low
Iceland 2006 [25] – – – – –
Hungary 2005 [26]
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Calcium Phosphorus Potassium Sodium Magnesium
3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months
Albania 2005 [1] Low Low Low Low Low Low
EC 1993 [2] – Low – – – – – –
Croatia 2004 [3] – – – – – – –
the Netherlands 1992 [4a] Low – Low – – – – Low
2000 [4b]
Ireland 1999 [5] High – –
DACH 2000 [6] Low Low Low Low Low Low Low
Belgium 2006 [7] – – – –
Romania 1990 [8] High High High – – – – High
Latvia 2001 [9]
France 2001 [10] – – – – – – – – –
The former Yugoslav Republic
of Macedonia
2001 [11] High High
Slovakia 1997 [12] – – – – High
Lithuania 1999 [13] – – – –
Bulgaria 2005 [14] Low Low Low Low – – – – Low Low
Nordic countries 2005 [15] – – – High – – – High
United Kingdom 1991 [16] High High
Bosnia and Herzegovina 2005 [17] Low – – High Low Low
Spain progr [18] Low Low – – High High
Serbia 1994 [19] – – – – – – – –
Italy 1996 [20] – – – – –
Russian Federation 1991 [21] – –
Estonia 2006 [22] – – – High – High
WHO/FAO 2004 [23] Low (cow milk) Low – – – – Low Low
Poland 1996 [24] High High Low Low High High
Iceland 2006 [25] – – – High – High
Hungary 2005 [26] Low
Table 4. Continued
Country Year Ref. Vitamin C Vitamin B6 Vitamin A Vitamin D Vitamin E
3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months
c. Overview of the level of recommendations between countries for minerals
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Iodine Iron Zinc Selenium Copper
3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months 3 months 9 months
Albania 2005 [1] High High Low High Low High High –
EC 1993 [2] – – Low – – Low –
Croatia 2004 [3] – – – –
the Netherlands 1992 [4a] – – Low Low High
Ireland 1999 [5]
DACH 2000 [6] High (no Low Low Low High
Belgium 2006 [7] High High –
Romania 1990 [8] Low Low – – – –
Latvia 2001 [9] High
France 2001 [10] – – – – – – – – – –
The former Yugoslav Republic
of Macedonia
2001 [11] High High High High High
Slovakia 1997 [12] High High
Lithuania 1999 [13] Low – – – –
Bulgaria 2005 [14] High High Low High Low
Nordic countries 2005 [15] – – – – –
United Kingdom 1991 [16]
Bosnia and Herzegovina 2005 [17] Low High High High Low Low Low High High
Spain progr [18] Low Low Low – –
Serbia 1994 [19] – – – – – – – – – –
Italy 1996 [20] – Low – – Low –
Russian Federation 1991 [21] – –
Estonia 2006 [22] – – – – –
WHO/FAO 2004 [23] High High – High Low –
Poland 1996 [24] High High High
Iceland 2006 [25] – – – –
–
Hungary 2005 [26]
d. Overview of the level of recommendations between countries for trace elements
Switz)
‘High’ means reference value is above the 75th percentile; ‘low’ means reference value is below the 25th percentile. Blank cells indicate that the reference value is between the 25th and 75th
percentile.
PUBLICATION 1 38
Table 5. List of European countries and international working groups with published reference values for vitamins and minerals.
Albania 2005 [1] Adopted from the literature (especially Linus Pauling
Institute) European Community (EC) 1993 [2]* Own
Croatia 2004 [3] Aligned with EU legislation
the Netherlands 1992, 2000, 2003 [4a] [4b] [4c] Own
Ireland 1999 [5] Adopted from EC and United Kingdom. Own recommendations for calcium,
iron (and folate and vitamin C)
Germany, Austria, Switzerland 2000 [6]* Own
Belgium 2006 [7]** Based on WHO/FAO, EC and European countries culturally and geographically
related to Belgium (United Kingdom, the Netherlands, France)
Romania 1990 [8] Own
Latvia 2001 [9] Own
France 2001 [10] Own
The former Yugoslav Republic of Macedonia 2001 [11] Based on WHO/FAO and United Kingdom
Slovakia 1997 [12] Adopted from unknown source
Lithuania 1999 [13] Own
Bulgaria 2005 [14] Based on WHO/FAO and IOM
Denmark, Finland, Norway, Sweden 2005 [15]* Own
United Kingdom 1991 [16]* Own
Bosnia and Herzegovina, entity: Republic of Srpska 2005 [17] Adopted from unknown source
Spain [18] Own
Serbia 1994 [19] Adopted from unknown source
Italy 1996 [20] Based on EC and FNB
Russian Federation 1991 [21] Own
Estonia 2006 [22] Based on Nordic Council of Ministers
WHO/FAO 2004 [23]* Own
Poland 1996 [24]** Based on United Kingdom, EC and FNB
Iceland 2006 [25] Shared with Nordic countries. Own recommendations on calcium and vitamin D
Hungary 2005 [26] Based on EC and IOM
*Background scientific report available in English language; **Polish and Belgian reference values have been revised in
2008. [1] Berisha A., Bader E., Deligia C and Claude Dop M. (2005) Nutrition country profile Republic of Albania.
[2] Commission of the European Communities (1993) Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food.
Thirty first series.
[3] Croatian National Official Gazzette 81 (2004).
[4a] Food and Nutrition Council (1992) Dutch dietary reference values 1989 (in Dutch: Nederlandse normen 1989), 2nd edn. The Hague.
[4b] Health Council of the Netherlands (2000) Dietary Reference Values: calcium, vitamin D, thiamine, riboflavin, niacin, pantothenic acid, and biotin. The Hague:
Health
Council of the Netherlands; publication no. 2000/12.
[4c] Health Council of the Netherlands (2003) Dietary Reference Intakes: vitamin B6, folic acid, and vitamin B12. The Hague: Health Council of the Netherlands;
publication no. 2003/04.
[4d] Health Council of the Netherlands (2008) Towards an adequate intake of vitamin D. The Hague:Health Council of the Netherlands; publication no.
2008/15E. [5] Food Safety Authority of Ireland (1999) Recommended Dietary Allowances for Ireland, Dublin.
[6] German Nutrition Society (DGE), Austrian Nutrition Society (OGE), Swiss Society for Nutrition Research (SGE), Swiss Nutrition Association (SVE)
(2000) Referenzwerte für die Nahrstoffzufuhr/Reference Values for Nutrient Intake, 1st edition in German. Frankfurt/Main.
[7] Hoge Gezondheidsraad (2006) Voedingsaanbevelingen voor Belgie,
herziening. [8] Institute of Public Health (1990) Recommended amounts.
Romania.
[9] Latvian Food Center (2001) Leteicamas energijas un uzturvielu devas Latvijas iedzivotajiem/recommended intake of energy and nutrients for Latvians.
[10] Martin A. (Guest Editor-in-Chief) (2001). Nutritional recommendations for the Grenc population. Sciences des aliments. International Journal of Food Science and
Technology 21, 309–438.
[11] Ministry of Health and Republic Institute of Health Protection (2001). Nutrient recommendations as addition to Guidelines for Healthy nutrition of the
population in Republic of Macedonia.
[12] Jajaba I., Simoncic R., Ginter E., Ondrejka J., Trusková I., Kalác J., Bzdúch V. (1997) Odporúcané výzivové dávky pre obyvateltvo Slovenska (8. revízia OVD).
Výz. Zdravie, 4, 2:25–29. Official Journal of Ministry of Health.28, part 7–8 Slovakia.
[13] Lithuanian Ministry of Health, NationalNutrition Center (order no. 510) (1999). Recommended dietary allowances for Lithuanian population (energy, protein, fat,
carbohydrate, vitamins and minerals). Valstybes zinios/Official Gezette, 1999, no. 102–2936.
[14] Ministry of Health (2005) Ordinance No23 from 19 July 2005 for physiological normative requirement (DRI) for nutrition of the population (State
Gazette
63/02.08.2005). Bulgaria.
[15] Nordic Council of Ministers (2004) Nordic Nutrition Recommendations 2004: Integrating nutrition and physical activity, 4th edition.
[16] Panel on DRVs of the Committee on Medical Aspects of Food Policy (COMA) (1991). Dietary Reference Values (DRVs) for food energy and nutrients for the
UK, Report on Health and Social Subjects 41.
[17] Public Health Institute of the Republic of Srpska (2005) Dietary guideline with reference values all micronutrients.Dragana Stojisavljevic, MD, Dusanka
Danojevic, MD, Janja Bojanic, MD, Ljubica Handric, MD; publication 2005/No 1Bosnia and Herzegovina, entity: Republic of Srpska.
[18] Moreiras O., Carbajal A., Cabrera L., Cuadrado C. (2007) Tablas de composición de alimentos Ediciones Pirámide (Grupo Anaya, SA). 11a edición revisada
y ampliada (278 pp) (ISBN: 978-82-2133-8). Book chapter: Ingestas recomendadas de energía y nutrientes para la población española, pp 227–230.
[19] Službeni Glasnik Srbije (1994) Pravilnik o normativima drustvne ishrane dece u ustanovama za decu. 50/94 (State Gazette RS (1994)
Recommendations for collective nutrition of children 50/94). Serbia.
[20] Società Italiana di Nutrizione Umana (1996). Livelli di Assunzione Raccomandati di Energia e Nutrienti per la Popolazione Italiana (LARN) Revision.
[21] The Ministry of Health of the USSR (1991) Russian Federation.
[22] Vaask, Sirje; Liebert, Tiiu; Maser, Mai; Pappel, Kaie; Pitsi, Tagli, Saava, Merileid; Sooba, Eve; Vihalemm, Tiiu, Villa, Inga (2006). Tervise Arengu Instituut.
Eesti toitumis- ja toidusoovitused. Estonia.
[23] World Health Organization, Food and Agriculture Organization of the United Nations (2004) Vitamin and minerals requirements in human nutrition, Second
edition. WHO:Geneva and FAO:Rome.
[24] Ziemlanski S., Bulhak-Jachymczyk B., Budzynska-Topolowska J., Panczenko-Kresowska B.,Wartanowicz M. (1996). Recommended dietary allowances for the polish
population (energy, protein, fat, vitamins and minerals).
[25] The Public Health Institute of Iceland (2006) Ráoleggingar um mataraeoi og naeringarefni fyrir fullorona og born frá tveggja ára aldri.
Reykjavík. [26] Antal M. (2005) Tápanyagtáblázat (New Food Composition Tables). Rodler I., Medicina Könyvkiadó Rt. Medicina Publishing Comp.,
Budapest.
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3 m 9 m Younger infants Older infants
Method Country Method Country
Thiamine 0.2–0.5 mg/d 0.2–0.6 mg/d Adequate intake from
human milk
DACH, WHO/FAO,
United Kingdom,
the Netherlands
Adequate intake from human milk DACH, WHO/
FAO, United
Kingdom
Interpolated between values for young infants  and for adults the Netherlands
Derived from adult values on the basis of energy expenditure EC, NNR
Riboflavin 0.3–0.6 mg/d 0.4–0.7 mg/d Adequate intake from
human milk
DACH, WHO/FAO,
the Netherlands
Adequate intakes from human milk DACH, WHO/
FAO
Intake related to a
satisfactory
United Kingdom Necessary intake to restore the erythrocyte glutathione reductase activation
coefficient
EC, United
Kingdom
riboflavin status
using erythrocyte
Derived from adult values on the basis of energy expenditure
Interpolated between values for young infants  and for adults
NNR
the Netherlands
Table 6. Comparison of reference values for water soluble vitamins for infants and methods used to estimate requirements
Range between countries Method on which the estimated requirements is based
glutathione
reductase activation
coefficient according
to a study on
Gambian infants
(Bates et al. 1982)
Niacin 2.0–8.0 mg/d 2.0–8.0 mg/d Adequate intake from
human milk
VitB12 0.3–0.5 mg/d 0.3–1.5 mg/d Adequate intake from
human milk
DACH, WHO/FAO,
the Netherlands
DACH, WHO/FAO,
the Netherlands
Derived from adult values on the basis of energy expenditure United Kingdom,
EC, NNR
Interpolated between values for young infants  and for adults the Netherlands
Adequate intake from human milk WHO/FAO
Intake required to
normalize methyl
United Kingdom Intake seen to correct biochemical deficiency as evidenced by methylmalonic
acid excretion
EC, United
Kingdom, NNR
malonic acid
excretion according
to a study carried
out in infants of
vegan mothers
(Specker et al 1990)
Interpolated from young infants  on the basis of weight increase DACH
Or interpolated between values for young infants  and for adults the Netherlands
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Table 6. Continued
Range between countries Method on which the estimated requirements is based
3 m 9 m Younger infants Older infants
Method Country Method Country
Folate 24–80 mg/d 32–80 mg/d Adequate folate DACH, WHO/FAO, Adequate intake from human milk WHO/FAO
intakes from human
milk
United Kingdom,
the Netherlands
Interpolated from young infants  on the basis of weight increase
Interpolated between values for young infants  and for adults
DACH
the Netherlands
Based on an intake of 3.6 mcg/kg body weight appeared to maintain plasma NNR, EC
levels  and showed maintained growth, heamopoiesis and clinical well
being
of the 20 infants involved in a trial (Asfour et al. 1977)
Set a value for formula fed infants  based on the adequate intake from human
milk plus intake from formula that produced lower red cell folate levels
than breast milk does but no differences in haemoglobin concentration,
weight gain or growth rate  according to a supplementation study in infants
(Foged et al. 1989)
United Kingdom
Vitamin C 25–50 mg/d 20–55 mg/d Based on vitamin C
content of breast
milk considering
maternal intake
Vitamin B6 0.1–0.5 mg/d 0.2–0.6 mg/d Usual vitamin B6
intakes from human
DACH, WHO/FAO,
United Kingdom,
the Netherlands, FR
DACH, WHO/FAO,
United Kingdom,
Based on vitamin C content of breast milk considering maternal intake DACH,  EC and
United Kingdom
From the reference value estimated for young infants WHO/FAO
Extrapolated from adult requirements by assuming a growth factor  of 1.3 NNR
From those for adults based on square heights France
Interpolated between values for young infants  and for adults the Netherlands
Usual intakes from human milk DACH, United
Kingdom
milk the Netherlands Derived from adult values on the basis of dietary protein intake, assuming
that 15% of energy  is provided from protein as for adult values and
then using values set for energy expenditures
Extrapolated from values for young infants  on the basis of metabolic size,
weight and growth, considering vitamin B6 content of breast milk, with
consideration of average maternal intakes and average plasma pyridoxal
phosphate (PLP) of nursing infants
DACH, United
Kingdom
EC
Interpolated between values for young infants  and for adults the Netherlands
Extrapolated values for adults using an adjustment for body height France
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3 m 9 m Younger infants Older infants
Method Country Method Country
Vitamin A 350–500 mcg/d 300–600 mcg/d Usual intakes from breast milk
Intakes considered sufficient to
DACH, WHO/FAO, the
Netherlands
United Kingdom
Based on usual intakes from
breast milk
Extrapolated from adult
DACH
NNR
build and maintain sufficient
liver stores
requirements by using metabolic
body weight and growth factors
Considered sufficient to build and WHO/FAO, United Kingdom, EC
Vitamin D 5–22.5 mcg/d 5–22.5 mcg/d Vitamin D intakes sufficient to
maintain plasma 25-OHD levels
within a range considered to
support adequate bone health
DACH, WHO/FAO, United
Kingdom, the Netherlands
Vitamin D intakes sufficient to
maintain plasma 25-OHD levels
within a range considered to
support adequate bone health
Took into account additional
intakes showing to have
DACH, WHO/FAO, United
Kingdom, EC, the Netherlands
NNR
Table 7. Comparison of reference values for fat soluble vitamins for infants and methods used to estimate requirements
Range between countries Method on which estimated requirements is based
maintain sufficient liver stores
Vitamin E 2.7–6 mg/d 2.7–6 mg/d Based on vitamin E content of
breast milk
Consider vitamin E intake in
relation to PUFA intake
maximal effect in linear growth
according to supplementation
studies in infants
Derived from adult values on an
energy allowance basis
France
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Table 8. Comparison of reference values for minerals for infants and methods used to estimate requirements
Range between countries Method on which estimated requirements is based
3 m 9 m Younger infants Older infants
Method Country Method Country
Calcium 210–800 mg/d 270–800 mg/d Usual calcium intakes from breast milk the Netherlands,
DACH, France
Based on usual intake from formula or food DACH
Based on calcium retention (factorial method for
calcium needed for growth, including skeleton,
urinary excretion and insensible losses) followed by
absorption studies
WHO/FAO, United
Kingdom
Based on calcium retention the Netherlands,
WHO/FAO, NNR,
EC, United
Kingdom
Phosphorus 100–400 mg/d 200–500 mg/d Based on breast milk content DACH, France Based on the infant formulae content DACH
On the basic principle of an equimolar relationship in
the body between calcium and phosphorus
United Kingdom On the equimolar relationship with calcium the Netherlands,
United Kingdom,
EC, NNR
The minimum level based on a relation of Ca/P of
1.7 molar, to lower the risk on tetany
the Netherlands On the amount required for growth derived from the
values for calcium with the Ca/P ratio for weight
gain of about 1.7 molar
France
Potassium 233–800 mg/d 425–1100 mg/d Based on the need to maintain electrolyte
homeostasis and for growth of cellular mass based
on factorial estimation of the urinary excretion, the
amount
DACH United
Kingdom
Factorial estimation United Kingdom,
EC
needed for growth and lean tissue synthesis, the
integumental and faecal losses (although the latter
may represent homeostatic excretion of excessive
intakes or losses incurred in maintaining sodium
homeostasis)
Sodium‡ 100–638 mg/d 180–850 mg/d Based on the requirement for maintenance and
growth, according to balance studies and body
analysis
Extrapolated values from adult requirements by using
metabolic body weight and growth factors (the
values of the adults are set by considering the
effect on blood pressure)
DACH Based on the requirement for maintenance and
growth, according to balance studies and body
analysis
NNR
DACH
On breast milk content of sodium United Kingdom On the daily increments in total sodium body
content allowing for the declining proportion with
age of extracellular fluid in body mass with an
allowance for dermal, faecal and urinary losses
United Kingdom
Magnesium§ 24–70 mg/d 48–100 mg/d On the basis of magnesium usual intake from breast
milk
DACH, WHO/FAO,
United Kingdom,
France
On the basis of magnesium usual intake from breast
milk
Extrapolated from the19–21 year age group, whose
values are estimated on the basis of balance studies
and taking the body weight into account
DACH, WHO/FAO,
NNR, United
Kingdom, France
the Netherlands
Out of 26 countries, only 14 have recommendations for potassium (Albania, EC, Ireland, DACH, Latvia, the former Yugoslav Republic of Macedonia, Nordic countries, United Kingdom, Spain, Italy, Estonia, Poland, Iceland,
Hungary).
‡Out of 26 countries, only 9 (Albania, Ireland, DACH,  Latvia, the former Yugoslav Republic of Macedonia,United Kingdom, Bosnia and Herzegovina, Poland, Hungary) have recommendations for sodium for infants.
§According to WHO/FAO, the magnesium in human milk is absorbed with substantially greater efficiency (about 80–90%) than that of formula milks (about 55–75%) or solid foods (about 50%).
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Zinc 1–5 mg/d 2–5 mg/d Based on zinc content in breast milk
Extrapolation from adult values of losses and
DACH
United Kingdom,
Based on zinc content in breast milk
Extrapolation from adult values of losses and
DACH
United Kingdom,
need for growth estimated with factorial
methods and balance studies
the Netherlands,
WHO/FAO
need for growth estimated with factorial
methods and balance studies
the Netherlands,
WHO/FAO
Based on metabolic weight the Netherlands Based on metabolic weight the Netherlands
Basal metabolic rates and considering
3 different bioavailabilities
WHO/FAO Basal metabolic rates and considering
3 different bioavailabilities
WHO/FAO
Extrapolated from adult values using EARs United Kingdom
for energy, which being based on basal
Iron‡ 0.3–12.5 mg/d 6–15 mg/d A requirement for dietary iron exists only DACH, WHO/FAO
metabolic rate have a weight component
Based on iron requirements for growth and DACH, NNR,
Table 9. Comparison of reference values for trace elements for infants and methods used to estimate requirements
Range between countries Method on which estimated requirements is based
3 m 9 m Younger infants Older infants
Method Country Method Country
Iodine 15–110 mg/d 40–135 mg/d Based on the iodine concentration in breast
milk, which depends on the mother’s iodine
intake
DACH, WHO/FAO,
United Kingdom
Balance  studies were used to estimate the
adequate mother’s  intake, and these are
valid also for old infants
WHO/FAO
Balance  studies were used to estimate the
adequate mother’s  intake, and these are
valid also for old infants
WHO/FAO Extrapolated from adults aged 19–24 y,
considering the iodine status in
balance studies, the connection between
iodine status and goitre frequency in
epidemiological studies, the relation
between long-term iodine intake and iodine
content of the thyroid gland, and
inactivation of active autonomous thyroid
adaptation mechanisms once a certain level
of iodine intake has been exceeded.
DACH
Derived values for older infants from adult
values, making a rough estimate on the
basis of energy requirements and body
weight
Based on data on goitre prevalence and
urinary iodine excretion in European
children and extrapolation from adult
values based on energy and growth
requirement
EC
NNR
from the 4th month due to the newborn’s
reserve of placental iron (Hb iron)
on iron basal losses United Kingdom
Extrapolation based on metabolic weight the Netherlands Extrapolation based on metabolic weight the Netherlands
Based on the amount of body stores of
iron and by the properties of the diet
(iron content and bioavailability)
Considers body weight and
energy expenditure
WHO/FAO
EC
Factorial method EC, NNR
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Table 9. Continued
Range between countries Method on which estimated requirements is based
3 m 9 m Younger infants Older infants
Method Country Method Country
Selenium 6–25 mg/d 8–40 mg/d During the first months of life low selenium the Netherlands, It valid also for older infants, with an United Kingdom
intake is sufficient as selenium has been
stored in the liver before birth; then,
recommendations for younger infants are
based on breast milk content of selenium
DACH allowance for growth taken into account
Interpolation of the estimates for 65 Kg adult
males of average normative
requirement + 2SD deviation assumed of
12.5%; nonetheless these values are
compatible with estimates of the selenium
intake from breast milk and formula
WHO/FAO Interpolation of the estimates for 65 Kg adult
males of average normative
requirement + 2SD deviation assumed of
12.5%; nonetheless these values are
compatible with estimates of the selenium
intake from breast milk and formula
Based on extrapolation from adult values of
the values of plasma glutathione peroxidase
activity on the basis of body weight
WHO/FAO
DACH, the
Netherlands, EC,
NNR, WHO/FAO
Copper 0.2–1.5 mg/d 0.2–1.5 mg/d Based on the amount of copper in breast
milk, due to fetal copper stores in the liver
and to the high absorption rate
the Netherlands,
DACH, United
Kingdom, France
Extrapolated from adult levels based on
body weight
Based on the copper tissue content and an
adjustment for loss of endogenous copper,
assuming an absorption of 50%
the Netherlands,
NNR
United Kingdom,
EC
Based on the liver stores France
Germany/Austria and Switzerland adopted two different values: Switzerland adopted those from the former WHO/FAO.
‡Different bioavailabilities (EC, UK: 15%), WHO/FAO’s value is the average of 4 different bioavailabilities, DACH does not take into account bioavailability.
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3. Concluding remarks
The summary in section 2 reflects great disparities in
the established current micronutrient reference
values for infants between European countries.  Envi-
ronmental and life-style factors can justify national or
regional differences only to a limited extent. In most
cases, the large variation of reference values is the
result of different methodological approaches used to
establish requirements and derived NIVs. This is illus-
trated in section 2 by the comparison of approaches
followed by seven committees to establish reference
values based   on their published scientific reports.
Further discrepancies are   found when converting
requirements to intake reference values on the basis
of body weight or of energy intake, for which the
selected normative data used are often not explained.
Similarly, different extrapolation methods used result
in different reference values. Furthermore, up to four
different age groups are defined within the first year
of life within which reference values are set. Other
than the transition from milk to complementary
foods, no clear explanations are given for the estab-
lishment of reference values for different age groups
in the first 12 months of life.
Thus, a major issue in understanding the existing
disparities of reference values is the lack of transpar-
ency in the documentation of the decision making by
the committees in charge. As an example, only 7 of 30
committees have published scientific reports that we
could use for comparing the approaches used to
establish reference values. Even in the available
reports, clear explanations on assumptions, decision
criteria and reference data are often lacking. Improv-
ing transparency in the process of setting micronutri-
ent reference values has major implications for
nutritional policy (e.g. development of nutritional
guidelines for infant feeding and regulation of infant
formula and follow-on formula composition), and
feeding practice.
Reference values need to be translated in nutri-
tional guidelines. When attempting to apply any
future guidelines to the infant population group,
attention should also be placed upon the social, cul-
tural and structural determinants of infant feeding
practices. Factors such as socio-economic and political
contexts, gender relationships, food availability, local
cultural practices, lifestyles, attitudes and beliefs are
known to play a role in child health and nutrition
(Pelto 1987). Poverty may be used as an example of
such a factor,for example in some Western countries
the lower the socio-economic group of the parents the
less likely the woman is to breastfeed or give comple-
mentary foods at the appropriate time (e.g. Ponza
et al. 2004; Heinig et al. 2006; Bolling et al. 2007;
Schiess et al. 2010), for a wide range of socio-cultural
reasons and embedded cultural norms (Sellen 2001;
Dykes 2005a,b, 2006; Spiro 2006; Scavenius et al. 2007;
Bhutta et al. 2008), placing the infant under consider-
able nutritional disadvantage. Low income mothers
and their infants are also more likely to eat an
‘unhealthy’ diet (high in fat, sugar and salt and low in
fruit and vegetables) than those on a higher income
(Attree 2005). Despite various initiatives aimed at
improving diet in poor households, evidence suggests
they have limited effectiveness among lower socio-
economic groups who are  their prime target (Lynch
et al. 2007). Instead interventions should be multi-
faceted and include measures to improve families’
socio-economic circumstances (Attree 2005). It is
therefore essential to recognize   any socio-cultural,
political and economic constraints upon women and
families in securing optimum nutritional standards for
their infants.
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Abstract
There is considerable variation in reference values for micronutrient intake during lactation across Europe. The
European Micronutrients Recommendations Aligned project aims  to harmonize dietary recommendations
throughout Europe. Recommended nutrient intakes during lactation are based on limited data and are often
extrapolated from known secretion of the nutrient in milk with adjustments for bioavailability, so that differ-
ences between   values can be partly ascribed to differences in methodological approaches and how these
approaches were applied. Few studies have considered the impact of lactation on the mother’s nutritional status.
Rather, focus has been  placed on the influence of maternal nutritional status on the composition of her breast
milk. Most common nutritional deficits in breast milk are the result of maternal deficiencies of the water-soluble
vitamins, thiamine, riboflavin and vitamins B6 and B12. Other than maternal vitamin A status, which to some
extent is reflected in breast milk, concentrations of fat-soluble vitamins and most minerals in breast milk are less
affected by maternal status. Factors relating to suboptimal maternal nutritional status during lactation include
maternal age, diet and lifestyle factors and spacing of consecutive births. Recent research is providing new
knowledge on the micronutrient requirements of lactating women. Identifying needs for research and improving
understanding of the differences in values  that have  been derived by various committees and groups across
Europe will enhance transparency and facilitate the application of dietary recommendations in policy-making
decision and their translation into recommendations for lactating women. Given  the wide variation in breast-
feeding practices across Europe, making nutritional recommendations for  lactating women is complex and
challenging. Thus, it is crucial to first examine the cultural practices within and across European populations and
to assess its relevance before making recommendations.
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Introduction
There is considerable variation in reference values for
micronutrient intake across Europe. The disparity is
caused by various factors such as differences in under-
lying  concepts, in the terminology used and in the
methodologies and assumptions made to define
micronutrient requirements and  to derive reference
values of intake (Doets et al. 2008).
The need  for harmonization of dietary recommen-
dations throughout Europe was recognized by the
European Commission in 2005 (Ashwell et al. 2008).
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The aim of harmonization is to improve understand-
ing of the differences in values that have been derived
by various committees and groups across Europe
and  to enhance their transparency to facilitate their
application in policy making decision. The
European Micronutrients Recommendations Aligned
(EURRECA) Network of Excellence has four phases
of activity. Research activity (RA) 1 evaluated best
practice for assessing intake and status methods and
collated current recommendations. RA 2 will apply
best practice developed in RA 1 to population groups
within a healthy population that may be vulnerable to
micronutrient deficiencies. RAs  3 and 4 will develop
and evaluate toolkits for dissemination of recommen-
dations. Women who are pregnant or lactating have
been identified by EURRECA as a vulnerable popu-
lation  group. While the nutrient requirements during
pregnancy are  discussed in this supplement by Berti
and colleagues, the aim of this paper   is to review
specific aspects of healthy lactating women in relation
to their micronutrient requirements.
Sources of disparity in nutrient
recommendations across Europe
Great disparities exist between reference values for
lactating women established in European countries
(Tables 1,2). Some countries have published their
own guidelines,  some have harmonized their recom-
mendations with  other countries [e.g. the German-
speaking countries (DACH) and the Nordic
countries] and some have adopted recommendations
suggested by others (e.g. Slovenia has adopted DACH
recommendations). These disparities have arisen
from the use of different concepts and sometimes
different data and because the expert committees
who set the recommendations often base their deci-
sions on judgements concerning the quality of the
available research (Pijls et al. 2009). As national ref-
erence values  are reviewed at different time points,
decisions may also  be based on different scientific
data (Doets et al. 2008). There is also discrepancy in
the terminology used to  describe reference values,
creating difficulties  with making comparisons across
countries. For  example, the  UK’s ‘dietary reference
values’ are constructed around the estimated average
requirement (EAR). The reference nutrient intake
(RNI) is the value  2 standard deviations above the
EAR. The RNI is equivalent to the population refer-
ence intake (PRI) used by the European Union (EU),
and the recommended daily allowance (RDA) is used
in other countries. Such divergent terminology and
concepts   can lead to confused messages that may
have a serious impact on policy and significant health
consequences (Pavlovic et al. 2007).
In relation to lactation specifically, as metabolic data
upon  which estimates of requirements are based are
often lacking for physiological  states such as lactation
because of practical difficulties or ethical limitations in
conducting research in women during these reproduc-
tive stages, differences between   values can also be
partly ascribed to differences in methodological
approaches and how  these approaches are applied
(Atkinson & Koletzko 2007). For example, Atkinson
and Koletzko (2007) compared the methods of
extrapolation used to determine recommended
intakes for vitamins A, C and E during lactation in the
USA/Canada, the Caribbean, the EU,  the Nordic
countries (Denmark, Finland, Iceland, Norway and
Sweden), the German-speaking countries (Austria,
Germany and Switzerland) and the UK. They found
that, although the general method of extrapolation
was similar across reports, the reference values applied
for nutrient composition of milk was often disparate,
Key messages
• The EURECCA network aims to harmonize the micronutrient recommendations for lactating women across
Europe.
• The micronutrient requirements of lactating women are influenced by a range of factors including the intensity
of lactation, maternal age, diet and lifestyle factors, and birth spacing.
• When making nutritional recommendations for lactating women attention must be paid to the social, cultural
and economic factors that influence what women may eat.
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Greece 1993 [9] PRI 0.9 1.4 70 10 * 1.1 1.7 16 1.9 350
Hungary 2005 [10] Safe intake 1.2 2 120 10 19 1 1.7 16 2.6 425
Iceland 2006 [11] RI 1.1 1.6 100 10 11 1.6 1.7 20 2.6 500
Ireland 1999 [12] RDA 0.95 1.4 80 10 * 1.1 1.7 16 1.9 400
Italy 1996 [13] RDA 0.95 1.4 90 10 * 1.1 1.7 16 1.4 350
Latvia 2001 [14] Recommended 1.3 2.2 150 10 12 1.6 2 20 3 300
average daily intake
Lithuania 1999 [15] RDA 1.2 2 100 10 14 1.4 1.9 16 4 480
Macedonia – Former YR 2001 [16] RDA 1.2 2 110 10 12 1.6 0.7 17.6 2.6 300
The Netherlands 1992 [17] AI or RI (riboflavin, 1.25 1.9 110 7.5 * 1.7 1.7 20 3.8 400
thiamine, B6, B12)
Nordic countries¶ 2005 [18] RI 1.1 1.6 100 10 11 1.6 1.7 20 2.6 500
Poland 2008 [19] RDI or AI 1.3 (1.2) 2 120 (115) 5 8 1.5 1.6 17 2.8 500
(vitamin D, E)
Portugal 2005 [20] RNI or safe intake 0.85 2 70 5 * 1.5 1.6 17 2.8 500
(vitamin A)
Russian Federation 1991 [21] Recommended level 1.2 2.3 115 12.5 12 1.8 1.97 16.8 3 300
of intake
Slovakia 1997 [22] RDA 1.2 2.3 130 10 18 1.4 1.8 20 2.6 300
Slovenia 2004 [23] RNI or AI 1.5 1.9 150 5 17 1.4 1.6 17 4 600
(vitamin E)
Spain 2007 [24] RI 1.3 2 85 10 17 1.1 1.7 18 2.6 500
UK 1991 [25] RNI 0.95 1.2 70 10 * 1 1.6 15 2 260
WHO/FAO 2004 [26] RNI 0.85 2 70 5 * 1.5 1.6 17 2.8 500
Table 1. Recommended intake level for vitamins for lactating women (values are inclusive of any increment for lactation)
Country
Units
Year Reference Reference value type Vitamin A
mg RE
Vitamin B6
mg
Vitamin C
mg
Vitamin D
mg
Vitamin E
Mg
Thiamine
mg
Riboflavin
mg
Niacin
mg NE
Vitamin B12
mg
Folate
mg DFE
Albania 2005 [1] RDA 1.3 (1.2) 2 120 (115) 5 19 1.4 1.6 17 2.8 500
Belgium 2009 [2] RDI 0.85 2 130 20 15 1.6 1.8 16 1.7 350
Bosnia and
Herzegovina
2005 [3] RDA 1.3 (1–6 m)
1.2 (7–12 m)‡
2.1 95 (1–6 m)
90 (7–12 m)
10 12 (1–6 m)
11 (7–12 m)
1.6 1.8 (1–6 m)
1.7 (7–12 m)
20 2.6 280
Bulgaria 2005 [4] RI 1.2 (1.1) 2 * 5 19 1.4 1.6 17 2.8 500
Croatia 2004 [5] RI 1.3 2 120 10 19 1.4 1.6 17 2.8 500
DACH countries§ 2004 [6] RNI or AI  (vit E) 1.5 1.9 150 5 17 1.4 1.6 17 4 600
Estonia 2006 [7] RI 1.1 1.6 100 10 11 1.7 1.7 20 2.6 500
France 2001 [8] PRI or AI (folate, 0.9 2 130 10 12 1.8 1.8 15 2.8 400
riboflavin, thiamine,
vitamin D,
vitamin E)
Values obtained from the web-based tool Nutri-RecQuest (described by Cavelaars et al. 2010). mg RE, mg retinol equivalent; mg NE, mg niacin equivalents; mg DFE, mg dietary folate equivalents; AI, estimated value for adequate
intake; AR, adequate area of intake; PRI, population recommended intake; RDA, recommended daily allowance; RI, recommended intake; RNI, recommended nutrient intake; LL, lower limit; UL, upper limit. *Reference value
is available but cannot be converted to the standard unit without making assumptions. Values  in parentheses indicate reference values for 18 years. ‡Indicating reference values for different stages of lactation. §DACH refers
to reference intakes for Germany, Austria and Switzerland. ¶‘Nordic countries’ refers to Denmark, Finland, Norway and Sweden. Iceland has adapted these so is referred to separately. References: [1] Berisha A., Bader E., Deligia
C and Claude Dop M, 2005. Albania. [2] Hoge Gezondheidsraad, Voedingsaanbevelingen voor België. Herziening 2009, HGR dossiernummer: 8309. [3] Public Health Institute of the Republic of Srpska, 2005. Bosnia and
Herzegovina, entity: Republic of Srpska. [4] Ministry of Health, 2005. Bulgaria. [5] Croatian National Official Gazzette, 2004. Croatia. [6] German Nutrition Society (DGE), Austrian Nutrition Society (OGE), Swiss Society for
Nutrition research (SGE), Swiss Nutrition Association (SVE)  2004. Germany, Austria, Switzerland. [7] Vaask, Sirje; Liebert, Tiiu; Maser, Mai; Pappel, Kaie; Pitsi, Tagli, Saava, Merileid; Sooba, Eve; Vihalemm, Tiiu, Villa, Inga, 2006.
Estonia. [8] Martin A, Guest Editor-in-Chief, 2001. France. [9] Commission of the European Communities 1993 Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food. [10] Antal
M. 2005. Hungary. [11] The Public Health Institute of Iceland, 2006. Iceland. [12] Food Safety Authority of Ireland, 1999. Ireland. [13] LARN (1996) Livelli di Assunzione Raccomandati di Energia e Nutrienti per la Popolazione
Italiana. Revision. Societá Italiana di Nutrizione Umana (SINU). [14] Latvian Food Center, 2001. Latvia. [15] Ministry of Health, 1999. Lithuania. [16] Ministry of Health and Republic Institute of Health Protection, 2001.The former
Yugoslav Republic of Macedonia. [17] Food and Nutrition Council, 1992. Netherlands. [18] Nordic Council of Ministers, 2005. Denmark, Finland, Norway, Sweden. [19] National Food and Nutrition Institute, Wydawnictwo Lekarsie
PZWL, Warsaw 2008. [20] World Health Organization (WHO), Food and Agriculture Organization of the United Nations 2004. WHO/FAO. [21] The Ministry of Health of the USSR, 1991. Russian Federation. [22] Ministry of
Health, 1997. Slovakia. [23] German Nutrition Society (DGE), Austrian Nutrition Society (OGE), Swiss Society for Nutrition research (SGE), Swiss Nutrition Association (SVE) 2004. Germany, Austria, Switzerland. [24] Moreiras
O, Carbajal AL, Cabera C 2007. Tablas de composicion de alimentos. Edicones Piramide 11a edicion revisada y ampliada. [25] Panel on DRVs of the Committee on Medical Aspects of Food Policy (COMA), 1991. United Kingdom.
[26] World Health Organization (WHO), Food  and Agriculture Organization of the United Nations 2004. WHO/FAO.
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Iceland 2006 [11] RI 1000 750 3100 * 280 200 15 11 55 1.3
Ireland 1999 [12] RDA 1200 950 3100 * * 160 15 12 75 1.4
Italy 1996 [13] RDA 1200 1200 3100 * * 200 18 12 70 1.5
Latvia 2001 [14] Recommended 1200 1200 4000 3300 340 200 18 19 75 3
Lithuania 1999 [15] RDA 1200 1200 2500 1500 380 200 20 15 * *
Macedonia – 2001 [16] RDA 1200 1200 2000 1500 360 200 20 22 125 2.5
former YR
The Netherlands 1992 [17] AR or AI 1000 900 LL, * * 300 LL, * 20 18 75 LL, 2 LL,
Nordic countries 2005 [18]
(Ca, Fe)
RI 900
1800 UL
900 3100 *
400 UL
280 200 15 11
150 UL
55
3.5 UL
1.3
Poland 2008 [19] RDI or AI 1000 (1300) 700 (1250) 5100 1500 320 (360) 220 (290) 18 12 (13) 70 1.3
Table 2. Recommended intake level for minerals for lactating women (values are inclusive of any increment for lactation)
Country
Units
Year Reference Reference value type Calcium
mg
Phosphorus
mg
Potassium
mg
Sodium
mg
Magnesium
mg
Iodine
mg
Iron
mg
Zinc
mg
Selenium
mg
Copper
mg
Albania 2005 [1] RDA 1000 (1300) 700 (1250) 5100 1500 320 (360) 290 9 (10) 12 (13) 70 1.3
Belgium 2009 [2] RDI or 1200 1000 3000 LL, 600 LL, 400 250 10 14 75 1.5
Acceptable 4000 UL 2000 UL
daily intake
Bosnia and 2005 [3]
(K, Na)
RDA 1200 1200 ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶
Herzegovina
Bulgaria 2005 [4] RI or AI (Ca, Na) 1000 (1300) 700 (1250) 5100 1500 320 290 9 (10) 12 (13) 70 1.3
Croatia 2004 [5] RI 1000 700 * * 310 290 9 12 70 1.3
DACH countries 2005 [6] RNI or AI (Cu) 1000 900 * * 390 260 20 10 30 LL, 1 LL,
70 UL 1.5 UL
Estonia 2006 [7] RI 900 900 3100 * 280 200 15 11 55 1.3
France 2001 [8] PRI or AI (Se) 1000 850 * * 390 200 10 19 60 2
Greece 1993 [9] PRI 1200 950 3100 * * 160 10 12 70 1.35
Hungary 2005 [10] Safe intake or 1200 930 3500 2000 450 200 15 13 75 1.4
suggested
maximum
intake (Na)
average daily
intake
(Ca, K, Na)
Portugal 2005 [20] RNI 1000 * * * 270 200 § § 35 (0–3 m) *
35 (4–6 m)
42 (7–9 m)
Russian Federation 1991 [21] Recommended 1200 1800 * * 450 150 33 25 * *
level of intake
Slovakia 1997 [22] RDA 1500 1500 * * 390 300 20 16 70 2.5
Slovenia 2004 [23] RNI or AI 1000 900 * * 390 260 20 10 30 LL, 1 LL,
(Cu, Se) 70 UL 1.5 UL
Spain 2007 [24] RI 1500 700 3500 * 450 155 18 25 75 *
UK 1991 [25] RNI or AI 1250 990 3500 1600 320 140 14.8 13 (<4 m) 75 1.5
(Cu) 9 (>4 m)
WHO/FAO 2004 [26] RNI 1000 * * * 270 200 § § 35 (0–3 m) *
35 (4–6 m)
42 (7–9 m)
Values obtained from the web-based tool Nutri-RecQuest (described by Cavelaars et al. 2010). mg RE, mg retinol equivalent; mg NE, mg niacin equivalents; mg DFE, mg dietary folate equivalents; AI, estimated value for adequate
intake; AR, adequate area of intake; PRI, population recommended intake; RDA, recommended daily allowance; RI, recommended intake; RNI, recommended nutrient intake; LL, lower limit; UL, upper limit. *Reference value
is available but cannot be converted to the standard unit without making assumptions. Values in parentheses indicate reference values for 18 years. ‡Indicating reference values for different stages of lactation. §Reference value
varies according to bioavailability. ¶Reference values are not referred to in the country-specific guidelines. References: [1] Berisha A., Bader E., Deligia C and Claude Dop M, 2005. Albania. [2] Hoge Gezondheidsraad,
Voedingsaanbevelingen voor België. Herziening 2009, HGR dossiernummer: 8309. [3] Public Health Institute of the Republic of Srpska, 2005. Bosnia and Herzegovina, entity: Republic of Srpska. [4] Ministry of Health, 2005.
Bulgaria. [5] Croatian National Official Gazzette, 2004. Croatia. [6] German Nutrition Society (DGE), Austrian Nutrition Society (OGE), Swiss Society  for Nutrition research (SGE), Swiss Nutrition Association (SVE) 2004.
Germany, Austria, Switzerland. [7] Vaask, Sirje; Liebert, Tiiu; Maser, Mai; Pappel, Kaie; Pitsi, Tagli, Saava, Merileid; Sooba, Eve; Vihalemm, Tiiu, Villa, Inga, 2006. Estonia. [8] Martin A, Guest Editor-in-Chief, 2001. France. [9]
Commission of the European Communities 1993 Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food. [10] Antal M. 2005. Hungary. [11] The Public Health Institute of Iceland,
2006. Iceland. [12] Food Safety Authority of Ireland, 1999. Ireland. [13] LARN (1996) Livelli di Assunzione Raccomandati di Energia e Nutrienti per la Popolazione Italiana. Revision. Societá Italiana di Nutrizione Umana (SINU).
[14] Latvian Food Center, 2001. Latvia. [15] Ministry of Health, 1999. Lithuania. [16] Ministry of Health and Republic Institute of Health Protection, 2001. The former Yugoslav Republic of Macedonia. [17] Food  and Nutrition
Council, 1992. Netherlands. [18] Nordic Council of Ministers, 2005. Denmark, Finland, Norway, Sweden. [19] National Food and Nutrition Institute, Wydawnictwo Lekarsie PZWL, Warsaw  2008. [20] World Health Organization-
(WHO), Food and Agriculture Organization of the United Nations 2004. WHO/FAO. [21] The Ministry of Health of the USSR, 1991. Russian Federation. [22] Ministry of Health, 1997. Slovakia. [23] German Nutrition
Society (DGE), Austrian Nutrition Society (OGE), Swiss Society for Nutrition research (SGE), Swiss Nutrition Association (SVE) 2004. Germany, Austria, Switzerland. [24] Moreiras O, Carbajal AL, Cabera C 2007. Tablas de
composicion de alimentos. Edicones Piramide 11a edicion revisada y ampliada. [25] Panel on DRVs of the Committee on Medical Aspects of Food Policy (COMA), 1991. United Kingdom. [26] World Health Organization (WHO),
Food  and Agriculture Organization of the United Nations 2004. WHO/FAO.
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creating differences between reports in their recom-
mended intakes.
It has been argued that the limited systematic
physiological difference in populations and climate
across Europe (with the possible exception of differ-
ence in sunlight exposure and consequent vitamin D
recommendations) does not justify the existing
disparities in nutrient recommendations. The
EURRECA network aims to develop   a common
framework that  uses consistent terminology in order
to  develop and maintain nutrient recommendations
based on the best current evidence (Pijls et al. 2009).
Challenges to establishing nutritional
recommendations for
lactating women
Lactation is a highly demanding state  for the mother
with a nutritive burden considerably greater than that
of pregnancy. The energy required to produce 1 L of
milk is estimated to be approximately 700 kcal, and
the milk secreted in 4 months of lactation represents
an amount of energy roughly equivalent to the total
energy cost of pregnancy (Cervera & Ngo 2001;
Picciano 2003). Although it is well acknowledged that
some  of this requirement originates from the nutri-
ents stored by the mother during pregnancy, there is a
need for lactating mothers to increase their food
intake in order to meet the elevated energy and
micronutrient requirements (Cervera & Ngo 2001).
Table 3 illustrates the percentage change in reference
values for lactation from non-pregnant, non-lactating
(NPNL) levels across Europe.
The duration and intensity of lactation (whether
the infant is breastfed exclusively or  only partially)
may have an impact  on a mother’s nutritional status.
For example, an exclusively breastfeeding woman has
much greater energy and nutrient needs (with the
exception of iron attributed to the potential protec-
tive effect of lactational amenorrhoea) than a woman
who is  only partially breastfeeding (Dewey 2004).
These aspects  of breastfeeding, however, have rarely
been considered in studies of the nutritional impact of
lactation in women. While the World Health Organi-
zation (WHO) recommends that infants should be
exclusively breastfed for the first 6 months of life with
breastfeeding continuing for up to 2 years of age or
beyond (WHO 2003), in reality, there are wide devia-
tions from this recommended norm both in terms of
duration and intensity, especially in industrialized
countries, challenging the meaningfulness of setting
standard  recommendations of nutrient intakes for
lactation.
Factors that could have a modifying
impact on nutritional
recommendations and reference
values in lactating women
Variability of breast milk
The calculation of recommended intakes during lac-
tation often employs a factorial approach that simply
sum the nutrient needs for a woman  of similar peri-
conceptional age who is not lactating with the amount
of nutrient delivered into an average volume of breast
milk, with adjustments for bioavailability in some
cases (Atkinson & Koletzko 2007). While the compo-
sition of breast milk is thought to be relatively stable
in well-nourished mothers, the infants’ average daily
intake of breast milk has been reported to vary
between studies (WHO 1998). The  volume of milk
consumed by the infant at each breastfeeding  has
been shown to be dependent upon a number of
factors, such as whether the breast that was being
suckled was the  more or less productive  breast,
whether the breastfeeding was unpaired, the time of
day and whether the infant breastfed during the night
or not (Kent et al. 2006).
Stage of lactation
Some countries/organizations investigated  (Bosnia
and Herzegovina, Portugal, the UK, WHO) have set
reference values for different stages  of lactation for
some nutrients (see Tables 1,2). It is argued that the
lactational period should not  to be divided into dif-
ferent stages such as early  and  late lactation for the
purpose of setting recommendations because evi-
dence supports that, as during pregnancy, physiologi-
cal adjustments in nutrient utilization occur during
this period that generally compensate for the shifts
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Albania 86 (71) 54 33 (28) * 27 27 45 21 17 25 0 (30) 0 (79) 9 0 3 (16) 93 -50 (-44) 50 (63) 27 44
Belgium 70 11 18 60 0 45 50 14 21 75 33 25 0 0 11 25 -26 75 25 25
Bosnia and Herzegovina 63 (50) 31 58 (50)      100 50 (38)      45 38 (31) 33 30 56 50 50 * * * * * * * *
Bulgaria 71 (57) 54 * 0 27 * 45 21 17 25 0 (30) 0 (79) 9 0 14 93 -50 (-44) 50 (63) 27 44
Croatia 63 0 100 100 90 0 0 -6 180 150 25 * * * 3 93 -36 * 40 13
DACH countries 88 58 50 0 42 40 33 31 33 50 0 29 * * 30 30 33 43 0 0
57 38 44
90 20 33
71 40 23
44 25 27
57 38 44
71 36 27
71 27 25
36 25 0
25 * *
83 0 0
Estonia 57 23 33 33 38 55 31 33 30 67 13 50 0 * 0 33 0
France 50 33 18 100 0 64 20 36 17 33 11 13 * * 8 33 -38
Greece 50 27 56 100 * 22 31 14 36 75 * 73 0 * * 23 -32
Hungary 50 54 33 100 29 11 31 14 30 42 50 50 0 0 50 33 0
Iceland 57 23 33 0 38 45 31 33 30 25 25 25 0 * 0 33 0
Ireland 58 27 33 100 * 22 31 14 36 33 50 73 0 * * 23 -7
Italy 58 27 50 100 * 22 31 14 27 75 20 20 0 * * 33 0
Latvia 30 10 50 100 0 33 25 25 0 0 0 0 0 0 -3 0 0
Lithuania 50 104 67 100 40 * 36 -6 33 60 20 33 0 0 27 33 33
Macedonia – Former YR 50 33 57 100 50 45 250 40 30 50 50 50 * 0 29 33 33
The Netherlands 56 27 57 200 * 55 55 54 36 33 0 * * * 27 * 33 140 13 10
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Table 3. Percentage change in micronutrient reference values during lactation compared to reference values for non-pregnant, non-lactating (NPNL) women (unless otherwise indicated the figure
represent an increase from NPNL levels)
Country
Nordic countries 57 23 33 33 38 45 31 33 30 25 13 50 0 * 0 33 0 57 38 44
Poland 86 (71) 54 60 (53) 0 0 36 45 21 17 25 0 (30) 0 (79) 9 0 3 (16) 47 (93) -44 60 (63) 27 4
Portugal 70 54 56 0 * 36 45 21 17 25 0 * * * 23 33 * * * *
Russian Federation 33 28 53 400 50 48 34 4 0 50 50 50 * * 13 0 * 67 * *
Slovakia 41 26 59 33 29 27 15 18 30 50 61 25 * * 11 81 20 45 35 25
Slovenia 88 58 50 0 42 40 33 31 33 50 0 29 * * 30 30 33 43 0 0
Spain 63 25 42 100 42 22 21 20 30 25 88 0 0 * 36 41 0 67 36 *
UK 58 0 75 * * 25 45 15 33 30 79 80 0 0 19 0 0 86 (36) 25 25
WHO/FAO 70 54 56 0 * 36 45 21 17 25 0 * * * 23 33 * * * –
Values in parentheses indicate percentage change for lactating women aged 18 years (Albania, Bulgaria and Poland), or values at different stages of lactation (Bosnia and Herzegovina and the
UK). *Unable to calculate percentage increase as either reference value is available but cannot be converted to the standard unit without making assumptions; reference value varies according to
bioavailability; reference value is not referred to in the country specific guidelines.
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in nutrient requirement with stages of lactation.
Atkinson & Koletzko (2007) assert that the grading
reference values do not appear to be based in strong
science and having more than one reference value for
lactation is impractical to implement.
Maternal age
Several countries have set separate reference values
for some micronutrients (typically vitamins A and C,
calcium, phosphorus, magnesium, iron  and  zinc) for
adolescent and adult lactating mothers    (see
Tables 1,2). It has be suggested that, as adolescence is
a period of rapid growth (approximately 50% of adult
body weight and 15% of final adult height is attained
during this stage of the life cycle; Rogol et al. 2000),
the additional nutritional demands of pregnancy and
lactation may have a significant impact  on the nutri-
tional status of adolescent mothers and  their breast
milk, particularly those who   are undernourished
(Hall Moran 2007). In studies of adolescents in Bang-
ladesh, for example, linear growth ceased during preg-
nancy and lactation, and lean body mass and percent
body fat declined by 6 months post partum (Rah et al.
2008). Lower ponderal and body compositional mea-
sures   were exhibited in those adolescents whose
infants survived through the neonatal period com-
pared with those who experienced a fetal loss or neo-
natal death, suggesting a depletion of maternal energy
and nutrient reserves to  meet the demands of both
pregnancy and lactation (Rah et al. 2010). In contrast,
Scholl et al. (1990, 1993) demonstrated that still-
growing US adolescents continued to grow in stature
and accrue  fat mass during pregnancy and lactation.
However, these young mothers had infants with lower
birthweight, particularly when the mother continued
to accrue higher amounts of arm or subscapular fat
late in gestation. Scholl et al. (1993) suggest that,
instead of mobilizing fat reserves  late in pregnancy to
enhance fetal growth, adolescent mothers appeared
to be reserving them for their own continued
development.
Other research has found that breastfeeding during
adolescence may have a protective role on bone mass
acquisition. While bone accretion rates peak during
pubertal growth because of associated hormonal
changes and adolescents experience bone mineral
density (BMD) loss during lactation, this effect seems
to be transient with subsequent repletion of BMD
once breastfeeding is ceased (Bezerra et al. 2004).
Chantry et al. (2004) reported that adjusted BMD
between ages 20 and 25 were 5–10% higher in women
who had breastfed as adolescents compared with
those who  had not. As higher peak BMD achieved
during adolescence protects against postmenopausal
osteoporosis (Rozen et al. 2003), breastfeeding during
adolescence may have  a protective role against this
disease. It has been suggested that the mechanisms of
BMD repletion (thought to be attributed to the rever-
sal of hormonal changes that caused bone loss during
lactation; Kalkwarf 1999) may  have a larger physi-
ologic effect when   bone mineral is still accruing
(Chantry et al. 2004).
It has been suggested that adolescents who are
still growing have   an increased demand for zinc
during lactation (Institute of    Medicine 2001).
Meeting zinc demands during lactation will depend
on the dietary supply, bioavailability and the capac-
ity for adaptation of zinc metabolism. While recent
evidence suggests  that the biochemical responses of
zinc to lactation are similar in adolescents  and
adults, significant correlations have been found
between the activity of zinc-dependent enzymes and
plasma  zinc in adolescents, which may suggest a lim-
iting action of poor maternal zinc status on the
metabolic adaptation capacity of this population
(Maia et al. 2007).
It is clear that, while  there is some evidence to
suggest that the nutritional demands of lactation may
have a differential impact on the nutritional status of
adolescent women, further research is needed to
clarify this.
Birth spacing and the recuperative interval
Reference values for lactation do not account for the
influence of birth   spacing on maternal nutritional
status. There is a large nutritional burden associated
with closely spaced consecutive   births, particularly
when lactation overlaps with pregnancy (Adair 1993).
The duration and intensity of lactation influences the
ability of the mother to replete her nutrient reserves
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Fig. 1. Conceptual model for the relationship between interpregnancy interval and maternal nutritional status. BMI, body mass index; NPNL,
non-pregnant, non-lactating; SES, socio-economic status (reproduced with permission from Dewey & Cohen 2007).
during the  interval between pregnancies (Dewey &
Cohen   2007). Pregnancies with short ‘recuperative
intervals’ (defined as  the amount   of  time that the
woman was not lactating prior to the next conception)
therefore are particularly vulnerable to nutrient
depletion. The complex interaction between the
factors that affect maternal nutritional status during
short recuperative intervals is shown in Fig. 1 (Dewey
& Cohen 2007). The nutritional consequences of a
short interpregnancy interval (whether combined
with duration and intensity of lactation or  not) are
influenced by many factors, such  as mother’s BMI,
dietary adequacy, physical activity level, socio-
economic status, education level, access prenatal care,
parity and morbidity. It is likely that the relationship
is context-specific, with positive  associations perhaps
more evident in undernourished populations (for a
more detailed discussion, refer to Dewey & Cohen
2007).
The majority of  studies on recuperative interval
have investigated its impact on   the infant, with
longer  birth intervals associated with a lower risk of
malnutrition and stunting in some populations. The
more limited data on maternal outcome   have
yielded inconclusive results. A recent systematic
review found only three studies that considered the
effect of recuperative interval on maternal anthro-
pometric status; none looked at the influence on
maternal anaemia or micronutrient status (Dewey &
Cohen 2007). Recuperative interval was found  to be
positively associated with maternal thigh skinfold
measurements (Merchant et al. 1990) and pregnancy
weight gain (Pebley & DaVanzo 1993) in studies
conducted in developing countries. Although weight
gain  between pregnancies in undernourished popu-
lations may be a positive maternal outcome, it may
not be true in developed countries where pre-
pregnancy non-obese weight has been positively
associated with increased risk of perinatal complica-
tion (Cnattingius et al. 1998, Villamor & Cnattingius
2006).
Factors based on diet and lifestyle
Aspects of dietary patterns and lifestyle, such as
quality  of foods, their combination with other foods
and their processing and storage,  can produce differ-
ences in nutrient absorption and metabolism, and
therefore have  an impact on nutritional recommen-
dations and reference values. Little research has been
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conducted on the wide variety of dietary factors that
could have a specific impact on lactating women.
There is some case study evidence that has demon-
strated severe vitamin B12 deficiency  in exclusively
breastfed infants of vegetarian and vegan mothers
(Weiss et al. 2004; Baatenburg de Jong et al. 2005;
Wagnon et al. 2005). Infants of vegetarian and vegan
mothers have low vitamin B12 levels at birth, and this
appears to be perpetuated if the vitamin B12-
deficient mother breastfeeds her infant (Specker et al.
1990). There is little information regarding the long-
term neurological effects of such deficiency, but these
may  include intellectual impairment, severe distur-
bance of gait and epilepsy (Graham et al. 1992). Veg-
etarianism is particularly common in adolescent girls,
with a prevalence of between 8% and 37% (Worsley
& Skrzypiec 1998). In addition, vegetarian teenagers
are  also more likely to exhibit health-compromising
dietary behaviours that could further compound the
nutritional challenge of lactation in this particularly
vulnerable population, such as frequent dieting,
binging, purging and  laxative use for weight control
(Neumark-Sztainer et al. 1997; Perry et al. 2001; Bas
et al. 2005) and alcohol use (Greene-Finestone et al.
2008). Studies have  yet to be conducted on the par-
ticular influence of vegetarian diets on the nutritional
status of lactating adolescents.
The negative   influence of maternal smoking on
breastfeeding duration has been well described in the
literature (Horta et al. 2001) and has been shown even
after adjusting for socio-economic group  and educa-
tion level (Hopkinson et al. 1992). Some studies have
suggested that smoking reduces daily milk output
by approximately 250–300 mL (Vio et al. 1991;
Hopkinson et al. 1992), possibly related to suppressed
prolactin   production in smokers (Anderson &
Schioler 1982; Widstrom et al. 1991). While it is well
documented that smoking has a negative impact on the
smokers’ nutritional status, particularly antioxidant
nutrients (Gibson 2005), little is known about the
influence of smoking on milk composition. It has been
suggested, however,  that smoking is associated with
significant reductions in milk fat concentration (Vio
et al. 1991; Hopkinson et al. 1992). The reduction in
milk  volume and fat content has been given  as an
explanation as to why women who smoke cease
to breastfeed earlier than those who do  not smoke
(Hopkinson et al. 1992). However, it is not yet clear
whether social and behavioural differences between
smokers and non-smokers play a greater role in early
cessation of breastfeeding than  physiological factors.
In their review, Amir & Donath (2002) claimed that, as
women who smoke are less likely to intend  to breast-
feed  and less likely to seek help  with breastfeeding
problems than non-smoking mothers, it cannot be
assumed that the relationship between smoking and
breastfeeding duration is a wholly physiological one.
Recent qualitative research emphasized the impor-
tance of the role of psychosocial factors reporting that
the reasons given by women who ceased to breastfeed
earlier related to their perceptions that smoking while
breastfeeding constituted a strong risk of harming
their baby (Goldade et al. 2008).
Socio-economic and cultural factors
It is recognized that lactation is not simply a matter of
transmitting nutrition from mother to  infant but a
crucial relational process between mother and child
(Dykes &  Hall Moran 2006). Thus, when assessing
nutritional requirements for lactating   women, it is
important to consider the socio-cultural, political and
economic constraints upon  women in securing
optimum nutritional standards for themselves and
their children. This is a crucial perspective as maternal
dietary and infant   feeding   practices relate signifi-
cantly to  cultural norms and associated constraints
(Sellen 2001; Dykes 2005; Spiro 2006; Scavenius et al.
2007; Bhutta et al. 2008); this explains the inevitable
wide variations in practice across the industrialized
world, with Europe being no exception.
Some cultural practices  affect micronutrient status
through routes other than access to foods and dietary
intake. For example,   South Asian   Muslim women
living in Europe may adopt a dress code of complete
or partial covering of the body. They are thus exposed
to little or no sunlight, affecting their vitamin D status,
which  can  have serious consequences during preg-
nancy  and lactation. Some cultural groups prefer to
avoid giving colostrum to the baby as it is seen as old
milk, a waste  product, contaminating and even poi-
sonous (Wambach & Riordan 2010). Weaning prac-
PUBLICATION 2 60
tices  (timing and spacing) of complementary foods
vary enormously across cultural   groups, and these
practices inevitably  affect the course, style and dura-
tion of lactation. In many European communities,
solid foods and soups are introduced well before the
recommended 6 months (WHO 2000).
There is a range of deeply embedded cultural prac-
tices that   will influence what the mother actually
selects to eat during lactation. For example, Hispanic
cultures, Chinese and some   South Asian groups
adhere to a set of implicit rules around ‘hot’ and ‘cold’
foods (Davis 2001; Wambach & Riordan 2010). This
does not relate to temperature but rather to a set of
foods  that are considered to affect the body in par-
ticular ways. The  practice of giving herbs and galac-
togogues (foods thought to enhance the quality
and/or quantity of milk) to the mother is a widespread
cultural practice that varies from community to com-
munity. These practices are commonly harmless but in
some cases may be problematic, for example, taking
some alcoholic drinks to stimulate lactation.
Socio-economic considerations at both macro- and
micro-levels influence the dietary intake of women so
for example, mothers living in conditions of poverty
may have little opportunity to obtain foods known
to be important during pregnancy and lactation
(Coufopoulos & Hackett 2009; Stapleton & Keenan
2009). These factors create challenges for such indi-
viduals in their achievement of the nutrient reference
value recommendations.
Influence of maternal nutritional status on
breast milk composition
Few studies have considered the impact of lactation on
maternal nutritional status. Rather, focus  has been
placed on the influence of maternal nutritional status
on the composition of her breast milk. The micronu-
trient content of  breast milk is relatively constant.
Although it is generally believed that  its nutritional
composition is preserved by homeostatic and nutrient
transport mechanisms that  can compensate for
increases and moderate decreases in maternal nutrient
supply, for many micronutrients, there is point at which
maternal dietary insufficiency will have consequences
in terms of maternal status and supply of nutrients to
the infant  via breast milk. There has been  very little
research conducted to help our understanding of the
situations in which maternal milk mineral concentra-
tion is low; however, it is likely that maternal malnu-
trition may impair mammary gland function and the
normal transport processes involved in the transfer of
micronutrients into the milk (Lonnerdal 2000).
Minerals
For many minerals, the infant is well protected by
maternal homeostatic processes such that moderate
deficiency or excessive dietary intake  does not signifi-
cantly  alter the levels of these micronutrients in the
mother’s milk (Domellof et al. 2004). Many minerals
are transferred into milk by  active transfer rather
than passive diffusion, and this process compensates
for variations in maternal mineral status. One notable
exception to this is selenium for which  breast milk
selenium concentration correlates well with maternal
selenium status (Lonnerdal 2000).
Many European countries recommend an increase
of at  least 33% in iodine intake from NPNL levels
(Table  3). This increase is required to accommodate
the changes in maternal thyroid metabolism to
support lactation, to supply sufficient iodine for milk
to meet the needs for growth and development of the
infant and   to ensure that pregnant and lactating
women   do not suffer from iodine deficiency post
partum (WHO 2007). However, Zimmermann &
Delange (2004) report that national surveys from
European countries reveal the median dietary intake
of iodine in women of child bearing age is around half
of  the recommended levels. The iodine content  of
milk is dependent upon the  mother’s iodine intake,
although there are compensatory mechanisms that
enhance iodine uptake by  the mammary gland of
iodine deficient mothers. Optimally, the iodine
content of mature milk should be in the range of
100–150 mg dL-1; above 75 mg L-1 is sufficient, but may
fall to values below 30 mg L-1 in areas with endemic
goitre (Azizi  & Smyth 2009). When maternal iodine
status is inadequate, the uptake of iodine   by the
mammary gland increases during lactation, creating a
deterioration of  the maternal iodine status by the
sequestration of some of the maternal iodine pool to
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the breast milk (Delange et al. 1988). In women with
marginal iodine status,   the demands of lactation
can precipitate clinical and biochemical symptoms,
including increased thyroid volume, altered thyroid
hormone levels and impaired mental function (Eltom
et al. 2000; Dorea 2002). Despite these effects, there is
currently insufficient   evidence to substantiate the
benefits  of zinc supplementation in lactating women
(Hess & King 2009).
An adequate supply of zinc is  essential for the
normal   growth and development of the fetus and
infant post partum. The high level  of zinc in colos-
trum, which is 17 times higher than that in blood,
illustrates the importance of zinc in the development
of a newborn (Almeida et al. 2008). Most European
countries recommend that zinc intake is increased by
at least 50% from NPNL levels (Table  3). Current
WHO recommendations for zinc intake during preg-
nancy and lactation range from 4.3 to 19 mg per day,
depending upon months post partum and the bio-
availability of  zinc  from the diet (WHO/Food and
Agriculture Organization of   the United Nations
(FAO) 2004). In a randomized double-blind, placebo-
controlled supplementation study of healthy women,
Krebs et al. (1995) reported that zinc concentration of
milk declines rapidly in the first 3 months post partum
from 59.4 to 16.7 mmol L-1, and this was not influenced
by dietary supplementation with 15 mg Zn per day. It
appears that an intake of 13 mg Zn per day during
lactation is adequate, and  increasing intakes beyond
this does not resulted in increased milk zinc concen-
tration (Moser-Veillon & Reynolds 1990; Hambidge
&  Krebs 2007). A number of studies of lactating
women with marginal zinc status have revealed that
homeostatic mechanisms can compensate for low
maternal dietary zinc intakes. The proportion of
dietary zinc absorbed in such women has been shown
to increase  by over 70% compared with non-lactating
women or pre-conception values (Jackson et al. 1988;
Sian et al. 2002). Evidence for a homeostatic response
to low dietary zinc intake was further illustrated in a
study  that reported that despite having dietary zinc
intakes that were 42% of the reference value, the zinc
status   of lactating women   (assessed using plasma
zinc concentrations) was not significantly lower than
those of non-lactating women (Moser & Reynolds
1983).While  such mechanisms act to enhance mater-
nal zinc availability for fetal growth and milk zinc
excretion, a consequence is that maternal reproduc-
tive function may be compromised (Hess & King
2009).
The transfer of calcium  to breast milk is a physi-
ologic response to lactation and facilitated by the
upregulation of  calcium absorption by  the mother,
conservation of excretion via kidney and mobilization
of calcium from the bone (Ritchie et al. 1998). As a
consequence, bone mineral density loss has been
shown to occur during lactation (Karlsson et al. 2001),
but this effect seems to be transient and seems to be
unrelated to calcium intake. Reference values for
calcium intake during lactation throughout Europe
range from no additional intake to an increase of over
80% from NPNL levels (Table  3). In those countries
that have set differential recommendations for lactat-
ing adolescents, reference values  for calcium exceed
those of  adult lactating women. There is little evi-
dence, however,  to suggest that there exists a signifi-
cant association between the mother’s calcium intake
(whether supplemented with calcium or not) and
levels in breast  milk. A randomized controlled trial of
pregnant and  lactating women in Gambia revealed
that, despite having low dietary intakes of calcium
(300–400 mg d-1) and low breast milk concentrations,
calcium supplements had no significant benefit in
terms of breast milk concentration (Jarjou et al. 2006).
Nor is there evidence to  suggest that supplements
prevent bone loss  during lactation or the recovery
of calcium status when breastfeeding is ceased
(Kalkwarf & Specker 2002).
Many European  countries recommend that iron
intake is reduced during lactation compared with
NPNL levels, albeit slightly less so for adolescent
mothers (Table 3). This is because women who exclu-
sively breastfeed are usually amenorrhoeic for at least
6 months, thereby conserving iron otherwise lost in
menses (approximately 0.5 mg Fe day-1). As iron is
secreted in relatively   low amounts in breast milk
(approximately 0.24 mg Fe day-1), net iron loss may
be lower than in non-lactating women (Dewey 2004).
Thus, breastfeeding may be protective against mater-
nal iron deficiency. In addition, lactating women have
been found to have greater serum ferritin concentra-
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tions than non-lactating women,  indicating elevated
iron   stores in those who breastfed (Kalkwarf &
Harrast 1998). This difference was not, however,
observed in haemoglobin status.
Vitamins
The concentration of many vitamins in breast milk is
dependent upon the vitamin status of  the mother,
with maternal deficiencies leading to  deficiencies in
the breastfeeding infant. Vitamins    of particular
concern in this  respect include thiamine, riboflavin,
vitamins B6 and B12 and vitamin A (Allen   1998;
Allen 2005; Langley-Evans 2009). As a consequence,
most European countries recommend an increased
intake of  all vitamins during lactation from NPNL
levels (Table 3). Of the B vitamins, B12 has been the
focus of the most research. Studies in B12-deficient
lactating women demonstrate an association between
the B12  status of  the mother and her infant at 3
months post partum (Casterline et al. 1997). Vitamin
A deficiency is a major public health problem in
developing countries, and strategies such as high-dose
supplementation of women post partum with vitamin
A is an effective way of ensuring adequate supplies to
the infant through breast milk (Sommer et al. 2002)
and preventing deficiency. Vitamin D deficiency has
gained a lot of interest in recent years, with the resur-
gence in the prevalence of rickets, particularly among
South Asian immigrants to western Europe (Alfaham
et al. 1995; Gillie 2004). Reduced sunlight exposure
attributed to the prevalent use of sunscreen creams,
sunlight avoidance or   the wearing of traditional
Muslim dress can contribute to vitamin D deficiency
in pregnant and lactating mothers, which can lead to
lowered breast milk concentrations (Seth et al. 2009).
The transfer of maternal vitamin  D to breast milk is
poor; therefore, supplementation of  the mother to
raise breast milk vitamin D levels is inefficient. Direct
supplementation of  the infant can be an effective
approach in the prevention of infantile rickets
(Kovacs 2008).
Conclusion
Recommended intakes during lactation are often
extrapolated from known secretion of the nutrient in
milk with adjustments for bioavailability, so that dif-
ferences between values can be partly ascribed to
differences in methodological approaches and how
these approaches are applied (Atkinson & Koletzko
2007). Recent research is providing new knowledge
on the micronutrient   requirements of lactating
women. Identifying needs for research and improving
understanding of the differences in values  that have
been derived by various committees and groups
across Europe will enhance transparency and facili-
tate the application of reference values in policy-
making decision and their translation into
recommendations for lactating women. Given the
wide variation in breastfeeding practices across
Europe, making nutritional recommendations for lac-
tating women is complex and challenging. It is crucial
to first examine the cultural practices   within and
across European  populations and to assess its rel-
evance before making recommendations.
Care should be taken to avoid assumptions that
providing the ‘correct’ information on nutritional
requirements during lactation will lead women to
make the ‘right choices’ in terms of their own nutri-
tion and the patterns and practices of breastfeeding.
This consumerist concept of decision making (knowl-
edge in – behaviour out) is based on an illusion of
linearity, and it ignores the complexities of decision
making. In reality, decisions will be made based on
macro-level (structural) factors such as socio-
economic and political contexts,  gender relationships
and food availability along with micro-level factors
such as local cultural practices, norms, lifestyles, atti-
tudes and beliefs (Pelto 1987; Bilson & Dykes 2009).
When attempting to apply any future nutritional
guidelines to this population group, attention should
also be made to the social, cultural and economic
factors that play a role in the eating behaviour and
subsequent nutritional status of adolescents, particu-
larly those who are pregnant or breastfeeding. In
many western countries, adolescent childbearing is
more prevalent among those with low levels of
income and education than among their better-off
peers (Singh et al. 2001). Poverty has been shown to
be a significant factor that limits the ability of some
childbearing adolescents to eat a healthy diet, even
in those who aspire to it (Burchett & Seeley 2003).
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Other socio-economic factors often experienced by
such groups, including unemployment, poor housing,
suboptimal mental and physical health, limited
access  to a wide  variety of reasonably priced foods
(Symon & Wrieden 2003), and an increased  likeli-
hood to   smoke during and following pregnancy
(Hamlyn et al. 2002) all contribute to difficulties in
tackling behavioural change. Thus, achieving dietary
change in this particularly vulnerable section
of the population presents a major public health
challenge.
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Abstract
A systematic review was conducted to summarize the evidence currently available from
randomised controlled trials (RCT) concerning the effect of iron intake of infants, children and
adolescents until 18 years of age on measures of neurodevelopment, including cognition and
psychomotor development, and on immunity. The Cochrane Library, MEDLINE and
EMBASE were searched up to and including February 2010. Studies were also identified by
checking the bibliographies of the articles retrieved. All RCTs with an adequate control group
in which iron supply was provided by natural food sources, fortified foods, formula, or
supplements until the age of 18 years were considered for inclusion. No language restrictions
were applied. 13 supplementation studies met the selection criteria for neurodevelopment
and 7 for immunity. Most of the studies had a high or moderate risk of bias. A large variety of
outcomes were reported. Overall, the studies showed a modest positive effect of iron
supplementation on cognition and psychomotor outcomes, especially in anemic infants and
children and after long-term supplementation periods (>2 months). A comparison of studies
using immunity outcome was not possible due to heterogeneity. Currently available evidence
is too incomplete to make evidence-based conclusions on the effect of iron on immunity.
List of abbreviations
ACT Alpha-1-Antil-Chymotrypsin
ADHD Attention Deficit Hyperactivity Disorder
ADHD-RS Attention Deficit Hyperactivity Disorder Rating Scale
AGP Alpha-1-Acid Glycoprotein
BRS Behavioural Rating Scale
BSID Bayley Scales of Infant Development
BTA Brief Test of Attention
CGI-S Clinical Global Impression- Severity
CPRS Conner’s Parent Rating Scale
CRP C-Reactive Protein
CTRS Conner’s Teacher Rating Scale
EURRECA European Recommendations Aligned
HVLT Hopkins Verbal Learning Test
ID Iron deficiency
IDA Iron deficiency anemia
IQ Intellectual intelligence quotient
MDI Mental Development Index
NAID Non anemic iron deficient
PDI Psychomotor Development Index
RCT Randomised controlled trials
SDMT Symbol Digit Modalities Test
URTI Upper Respiratory Tract Infections
VSAT Visual Search and Attention Test
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INTRODUCTION
During the first year of life, the body iron content increases markedly. In healthy term infants,
iron stores at birth comprise most of the iron requirements for the first 4–6 months. From the
4th month, the requirement for dietary iron increases to an estimated 0.78 mg/day due to the
stepwise depletion of endogenous stores and rapid growth with an expansion of blood
volume and increased tissue and storage iron [1]. Rapid growth with high iron needs makes
infants and young children a particular risk group for iron deficiency anemia (IDA), especially
infants and young children aged 6-24 months [2]. Because of rapid growth and increased
iron demands during puberty, adolescents are another risk group for development of IDA,
especially adolescent girls due to menstrual losses [3, 4]. In addition to inadequate intake,
factors which could influence iron status may include strenuous exercise, pregnancy, low
socioeconomic status and ethnicity, as well as disease-induced malabsorption and chronic
blood loss [5] or polymenorrhea in girls [6, 7]. Prevalence estimates of iron deficiency (ID) in
adolescent girls range from 9% to 40%, depending on the population studied and the criteria
used to define ID [8]. In children below 4 years of age the estimated prevalence of ID ranges
from 20% in industrialized countries to 39% in non-industrialised countries [9]. Anaemia is
considered to be a public health problem when the prevalence of low haemoglobin
concentrations exceeds 5% in the population. The severity of the public health problem of
anaemia is classified as mild (5.0–19.9%), moderate (20.0–39.9%) or severe (≥ 40%)
according to the prevalence of anaemia in the population [10]. Worldwide, the estimated
prevalence of IDA among preschool-aged children is 25%; 40% among schoolchildren, and
30–55% among adolescents [11].
ID and IDA can have a serious impact on infants’ and children’s health and later
development: alteration of the immune status, adverse effects on morbidity, delayed
behavioural and mental development, below average school achievements and growth
retardation [12], as well as adverse effects on cognition that may or may not be reversible
with iron treatment [8, 13]. However, although various studies have been performed using
neurodevelopment outcome to assess iron requirement in infancy and childhood, results
have been inconclusive. Different populations have been studied at different ages with
different developmental tests, which makes difficult to compare the studies [14]. Particular
interest has been given to preschool and school children. Most observational studies in
children have found a significant association between IDA and poor cognitive and motor
development [15, 16] showing that anaemia is associated with lower scores on testing of
intelligence quotients. Children 9-11 years old with IDA obtained significantly lower scores in
a standardized educational achievement test than did iron-replete children [17]. It is not clear,
however, whether the iron deficiency causes the delay or merely whether the two findings
are associated evidence of an underprivileged environment. It is also possible that an early
neurodevelopment insult caused by IDA may not result in detectable psychomotor delay
during infancy, but symptoms such as deficits in attention and school performance may
appear later, in older children, young adolescents and adults [14]. There is increasing
evidence that low iron status, as a systemic condition, adversely influences physiological
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functioning not only due to reduced haemoglobin synthesis, but also because of decreased
activity of iron containing enzymes in the brain [18]. Since in iron deficiency iron appears to
be preferentially channelled to hemoglobin synthesis, the brain may become iron depleted
when intake is insufficient even if the individual is not yet anemic [18]. A number of animal
studies show that ID changes the myelination of neurones, neurometabolism,
neurotransmitters and gene/protein profiles before and after iron repletion at weaning [19].
Human infants who experience iron deficiency during the first 6–12 months of life are likely to
experience persistent effects of the deficiency that alter functioning in adulthood. A lack of
sufficient iron intake may significantly delay the development of the central nervous system
as a result of alterations in morphology, neurochemistry, and bioenergetics [20].
The role that iron plays in the neurodevelopment of anemic and non anemic iron deficient
(NAID) infants, children and adolescents is not fully understood. Resistance to iron treatment
was observed in most trials of children <2 years of age with IDA, but not in older children. In
children >2 y of age and in adolescents with IDA, evidence suggests beneficial effects of iron
treatment on cognitive or behavioral function; however, the insufficient number of studies,
often associated with different confounders, prevents a thorough assessment.
Additionally, it is well known that ID causes impaired immune response and adverse effects
on morbidity [12, 21], but the relation between iron intake and morbidity is still controversial.
The EURopean RECcommendations Aligned (EURRECA) Network of Excellence attempts to
consolidate the basis for the definition of micronutrient requirements across Europe, taking
into account relationships among intake, status and health outcomes [22]. Systematic
reviews are being conducted on those micronutrients that are deemed to be of major
importance for certain population groups, following a standardised methodology. This paper
aims to review data from all available RCTs which met EURRECA’s high quality standards,
to ascertain whether there is a beneficial effect of iron on neurodevelopment, including
psychomotor development and cognition, and on immune function in infants, children, and
adolescents.
METHODS
Search methods for identification of studies
Structured electronic searches were conducted (over all years until February 2010) on
MEDLINE, EMBASE (both on Ovid) and the Cochrane Library CENTRAL database. A
general search strategy was devised which included terms for “[study designs in humans]
AND [intake or status] AND [iron]”. Both indexing and text terms were used and each search
strategy was further adapted for the individual databases used. The search was not limited
by language. To ensure comprehensive retrieval of relevant articles a multi-database search
was conducted. The reference lists of retrieved articles and of published reviews were also
checked for relevant studies.
Criteria for the consideration of studies for this review
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Studies had to fulfil the following two criteria to be included in the review: (1) investigate the
effect of iron intake from supplements, fortified foods or natural dietary sources on any
measures of neurodevelopment, including cognition and psychomotor development, or on
immune response and (2) be randomised controlled trials with an adequate control (placebo
or no intervention) in apparently healthy infants, children and adolescents from birth to 18
years of age at the time of the intervention. Subjects with ID or IDA but otherwise healthy
were included. The effect of iron had to be clear: combined interventions with more than one
micronutrient or with lifestyle intervention which did not study the effect of iron separately
were not considered. Baseline data for the measured outcomes had to be reported.
Selection of studies and data extraction
First, studies were screened by two independent reviewers on the basis of title and abstract
to exclude any reference clearly not meeting the review criteria. 10% was assessed in
duplication. The duplicate checks were performed first and any discrepancies discussed
before the remainder of the references were screened. Any potentially relevant references
were then located as full texts to be assessed according to the inclusion criteria. Full texts
were assessed by two independent reviewers and disagreements were settled through
discussion. Only those papers meeting all the criteria were included in the review. Data were
extracted into a standardised database. Data extracted included bibliographic details,
methodological details, population characteristics, study groups details and outcome data.
10% of the total papers were extracted in duplicate and any disagreements were discussed
to settle uniform data extraction.
Assessment of risk of bias in included studies
In order to assess the quality of the study and the risk of bias, the following indicators of
internal validity specific to the RCT methodology were collected during data extraction: (1)
method of sequence generation and allocation, (2) blinding, (3) potential funding bias, (4)
number of participants at start, (5) dropouts and dropout reasons, (6) dose check, (7) dietary
intake data reported, (8) outcome comparability and reproducibility, and (8) similarity of most
and least exposed groups at baseline. Based on these indicators, two reviewers decided on
the overall risk of bias. Disagreements were resolved by discussion. The criteria for judging
these indicators were adapted from the Cochrane Handbook [23].
RESULTS
The effect of iron neurodevelopment, including cognitive function and psychomotor
development
Table 1 shows the key characteristics of the included studies assessing neurodevelopment,
including cognitive function and psychomotor development, in infants, children and
adolescents.
In total, thirteen studies were eligible and were included in the review. Only three of the
studies were performed in infants. Two included infants until 12 months of age [24, 25], and
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one of them included also children until 24 months of age [26]. The three of them were
supplementation trials, with iron alone [24, 26] or with iron combined with zinc [25]. The
studies were performed in Indonesia, Guatemala and Turkey. One of them was performed in
non anemic infants [24], while the other two included anemic and non anemic infants [25,
26]. One study was a short-term intervention study and used a dosage of ferrous ascorbate
of 5 mg/kg during 1 week [26], whereas the other two studies used doses of ferrous sulphate
10 mg/d and 1mg/kg&d during 6 and 3 months, respectively [24, 25].
Ten studies assessed cognitive function in children and/or adolescents 1-18 years old.
Excepting one study with a fortified food product [27], all provided iron supplements: in form
of ferrous sulphate alone (8 studies) [8, 13, 17, 24, 25, 28-32], ferrous sulphate combined
with vitamin C [33], or ferrous fumarate combined with multivitamins [34]. Seven studies
included children 1-13 years old [13, 17, 28, 29, 32-34], two included children and
adolescents from 8 to 15 years of age [30, 31] and one study included adolescents 13-18
years old [8]. Two studies were performed on females only [8, 30] while the rest were
performed on mixed population. Three studies were conducted in Europe: Greece [34],
France [32] and England [33], one in the USA [8], and the other six studies in Asia: two in
India [30, 31], two in Indonesia [13, 29] and two in Thailand [17, 28]. The dosages of
supplemented iron varied widely between the studies. One of the trials provided 15 mg
elemental iron daily, given as ferrous fumarate [34]. Doses between 10 and 60 mg of
elemental iron daily in form of ferrous sulphate were used in 12 studies (see Table 1). Bruner
et al (1996) used markedly higher doses, 2x2 tablets of 325 mg (1300 mg in total) ferrous
sulphate daily in adolescent girls, that is equivalent to 260 mg iron daily [8]. Two studies
conducted in Indonesia used different doses of iron according to the weight of the children, 2
and 3 mg/kg&day [13, 29]. Pollit et al. (1989) increased the dose from 10 mg/d in the first two
weeks, to 20 mg/d in the following 14 weeks [17]. The duration of the interventions ranged
from 8 weeks to 4 months. In two Indian studies girls were treated 2x60 days in a school year
[30, 31]. In most of the studies, children received the iron supplement daily during the
intervention, except in the study by Sungthong et al. where children received 60 mg
elemental iron 5 times per week (one group) or the same dose once a week [28]. Two
studies [30, 33] were performed in anemic children, one study in NAID girls [8], one in
apparently healthy children [28] and five studies in both anemic and nonanemic children [29,
31, 34], two of them including a NAID group [13, 17]. In addition, Konofal et al. performed
their study in hyperactive children with normal hemoglobin level, but with low ferritin status
[32].
The three trials in infants used the Bayley Scales of Infant Development (BSID). Mental
Development Index (MDI) and Psychomotor Development Index (PDI) scores were derived
from the results, and one trial additionally reported Behavioural Rating Scale (BRS).
Assessment of neurodevelopment in older children varied between the studies. Idjradinata
and Pollit (1993) performed a trial in children 12-18 months old using the Bayley Scales too
[13], while Aukett and Parks (1986) used 24 items from the Denver developmental screening
test validated by the Bayley scale in children 17-19 months old [33]. Two studies conducted
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in India used the same tests for assessment of cognitive function in children 8-15 years old:
Clerical Task test, Digit Span test, Mazes test and Visual Memory [30, 31]. Simple reaction
time, continuous performance task and oddity learning tasks were used by Metallinos-
Katsaras et al. (2004) [34], while Bruner et al. (1996) used Brief Test of Attention (BTA),
Symbol Digit Modalities Test (SDMT), Visual Search and Attention Test (VSAT) and Hopkins
Verbal Learning Test (HVLT) [8]. In three studies the authors measured the intelligence
quotient (IQ) in children before and after intervention [17, 28, 29]. The study by Konofal et al.
was performed in hyperactive children, using the following tests: Conners Parent Rating
Scale (CPRS), Attention Deficit Hyperactivity Disorder (RS), Conners Teacher Rating Scale
(CTRS) and Clinical Global Impression- Severity (CGI-S) [32]. The large diversity of tests
employed in the different studies hampered any quantitative comparison of results or meta-
analysis.
A trial in Guatemala that provided short term supplementation for 1 week to infants and
children until 24 months of age found no benefit of iron supplement when testing with the
BSID [26]. A study in Turkey with a longer supplementation period (3 months) showed no
significant change in developmental test scores in non anemic infants [24]. In contrast, a
study in Indonesia with a 6 months supplementation period and a considerably higher
sample size of 680 subjects, compared to the study in Guatemala with 68 infants and the one
in Turkey with 24, indicated a positive developmental outcome related to motor development
as assessed by BSID in all infants [25]. The latter study also used the BRS to assess infants.
No significant differences in BRS scales between the iron supplementation and placebo
group were found.
A study in 12-18 months old children showed that iron treatment significantly improved BSID
results, even reaching the performance level of iron-sufficient children, unlike the group
treated with placebo (p<0.001) [13]. In another study, the supplementation with iron (or
placebo) did not affect the results in NAID children or in non-anemic children. In a group of
anemic toddlers of similar age, 17-19 months, 31% achieved 6 or more new skills after
treatment with iron, vs. 12% in the placebo treated group (p<0.05), assessed by Denver
developmental screening test [33]. In another trial, anemic children 3-4 years old made
significantly fewer errors of commission (14% higher specificity, p<0.05) and exhibited 8%
higher accuracy (p<0.05) after iron treatment than those given placebo, suggesting improved
discrimination and selective attention, although no effects were found on the Oddity Learning
task. These positive effects of iron were not seen among the children with good iron status
[34].
In a study by Pollitt and coworkers (1989), the IQ and scholastic achievement significantly
increased in anemic and to a lesser degree in non-anemic iron deficient children 9-11 years
old, after 10 mg/d iron supplementation in the first 2 weeks and 20 mg/d in the following 14
weeks [17]. Interestingly, Sungthong et al. (2004) reported a higher increase in IQ in 6-13
years old children treated with 60 mg iron once weekly for 16 weeks (6±12 points) or placebo
(6±12 points) than in children treated with the same dose of 60 mg iron 5 days a week
(3±12), while no difference in learning achievement was found among groups [28]. No
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statistically significant improvement in IQ was found in an Indonesian study on children who
received 2 mg/kg&d iron for 3 months compared to the control group, but improved learning-
achievement scores were detected in anemic children treated with iron [29].
Sixty days of supplementation with 30 or 40 mg iron per day in 8-15 years old anemic boys
induced a significant improvement of all cognitive functions comparing to placebo group
(p<0.05), except for Mazes test in the 30 mg/d group. No difference between the iron and
placebo group was found in nonanemic boys [31]. Girls of the same age were treated for
2x60 days with 60 mg/d iron. Significantly better scores in Clerical Task test, Digit Span test
and Mazes test were reported after 8 months in the iron vs. placebo treated group (p<0.05)
of anemic girls, but not after 4 months [30]. Similar results were found by Seshadri and
Gopaldas but, additionally, they reported improved Mazes test in non-anemic girls too, after
supplementation with iron [31]. Markedly higher doses of 260 mg/d iron, given to NAID
adolescent girls for 8 weeks, lead to significantly better results in a test of verbal learning and
memory compared to girls in the placebo group (p<0.02) [8].
Twelve weeks of iron supplementation improved Attention Deficit Hyperactivity Disorder
(ADHD) symptoms in 5-8 years old children with low serum ferritin levels. There was a
progressive significant decrease in the ADHD Rating Scale (ADHD-RS) on the iron group (p
< 0.008), but not in the placebo group. Improvement of CPRS (p 0.055) and CTRS (p 0.076)
with iron supplementation therapy failed to reach significance. The mean CGI-S significantly
decreased at 12 weeks (p < 0.01) in the iron treated group, but it did not change in the
placebo group [32].
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Table 1: Summary of main characteristics and main results of included trials assessing
neurodevelopment, cognitive function and psychomotor development
Author,year
of
publication,
country
Population
characteristics
(number of
subjects, age)
Intervention
(iron dose,
number of
subjects in
each group)
Control Duration of
intervention
(weeks of
months)
Outcomes Main results
Aukett and
Parks, 1986
[33]
England
N=110
Anemic children
17-19 mo of age
Ferrous
sulphate 24
mg/d +
Vitamin C 10
mg/d
n=48/54
Vitamin C +
placebo
n=49/56
2 mo Neurodevelopment
psychomotor
development
24 items from the
Denver
developmental
screening test
More of the
children who
received the iron
achieved the
expected rate of
development as
compared to
those not
receiving iron.
Bruner et al.
1996 [8]
USA-
Baltimore
N=81
Non-anemic iron
deficient
adolescents
13-18 y of age
Ferrous
sulphate 260
mg/d
N=37/39
Placebo
n=36/39
2 mo BTA-auditory
SDMT-visual
VSAT
HVLT
Girls who
received iron
performed better
on a test of
verbal learning
and memory
than girls in the
control group
Idjradinata
and Pollitt,
1993 [13]
Indonesia
N=126
Anemic and non
anemic children
12-18 mo of age
Ferrous
sulphate, 3
mg/d
1. IDA
n=24/25
2. nonanemic
ID n=29/29
3. iron
sufficient
n=22/24
Placebo
1. IDA
n=23/25, 2.
nonanemic
ID n=14/15,
3. iron
sufficient
n=22/23
4 mo BSID (MDI, PDI) The poor
performance of
12-18 month-old
iron deficient
anaemic infants
in the Bayley
scales prior to
the treatment.
4 mo treatment
with FeSO4
improved
performance to
the level of
performance of
iron-sufficient
intants
Kashyap et
al. 1987 [30]
India
N=207
Anemic school
girls
8-15 y of age
Ferrous
sulphate 60
mg/d
n=65/83
Placebo
n=65/83
4 mo Clerical Task, Digit
Span
Maze test, Visual
Memory
Prophylactic
supplementation
of 60 mg
elemental iron for
60 days at a
stretch, twice in a
school year,
improved
concentration,
discrimination,
perception and
visual motor
coordination
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Author,year
of
publication,
country
Population
characteristics
(number of
subjects, age)
Intervention
(iron dose,
number of
subjects in
each group)
Control Duration of
intervention
(weeks of
months)
Outcomes Main results
Konofal et al.
2008 [32]
France
N=23
Children with
ADHD, non
anemic, iron
deficient
5-8 y of age
Ferrous
sulphate 80
mg/d
N=16/18
Placebo
n=5/5
3 mo CPRS
RS
CTRS
CGI-S
Iron
supplementation
improved ADHD
symptoms in
children with low
serum ferritin
levels
Lind et al.
2004 [25]
Indonesia
N=680
Anemic and non
anemic infants
6 mo of age
Ferrous
sulphate 10
mg/d
(n=167/170)
Ferrous
sulphate 10
mg/d + Zinc
sulphate 10
mg/d
(n=160/170)
Zinc sulphate
(n=161/170)
Placebo
(n=162/170)
6 mo BSID (MDI, PDI and
BRS) assessed at
12 mo of age
Single
supplementation
with iron
significantly
improved
psychomotor
development
Combined
supplementation
had no
significant effect
on development.
Lozoff et al.
1982 [26]
Guatemala
N=68
Infants with and
without mild IDA
from 6 to 24 mo
of age
Ferrous
ascorbate 5
mg/kg&d
(n=12/15
anemic,
n=17/19 non
anemic)
Placebo
(n=12/13
anemic,
18/21 non
anemic)
1 w BSID (MDI, PDI)
assessed 1 week
after start of
treatment
Developmental
deficits in anemic
group prior to
treatment.
Lack of rapid
improvement
with short term
oral iron therapy.
Metallinos-
Katsaras et
al. 2004 [34]
Greece
N=123
Anemic and non
anemic
3-4 y of age
Ferrous
fumarate +
multivitamins
15 mg Fe/d
n=27/27
Multivitamins
n=17/17
2 mo Simple reaction
time, continuous
performance task,
oddity learning task
(ODL1), ODL2,
ODL3
Iron
supplementation
of iron-deficient
anemic
preschoolers
improved
cognitive
function,
specifically
discrimination
and selective
attention
Pollitt et al.
1989 [17]
Thailand
N=1389
Anemic, and
non anemic
children with ID
9-11 y of age
Ferrous
sulphate
50mg Fe/d
for 2 w and
100mg Fe/d
for 14w
No numbers
per group
Placebo
No numbers
per group
4 mo IQ, Thai language,
Mathematika
Positive
association
between iron
status and IQ
and language
school
achievement
test. No support
for the internal
validity of the
hypothesis that
this association
is causal
Seshadri et
al. 1989 [31]
India
N=178
Anemic and non
anemic
8-15 y of age
Ferrous
sulphate
boys 30
mg/d,
n=16/16
boys 40
mg/d,
n=16/16
girls 60 mg/d
n=65/65
Placebo
boys n=16/16
placebo girls
n=65/65
2 mo Clerical Task, Digit
Span
Maze test, Visual
Memory
In both
supplemented
group of anemic
boys 69%
improved
cognitive
function, except
for mazes in 30
mg Fe group. No
difference in
placebo and iron
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Author,year
of
publication,
country
Population
characteristics
(number of
subjects, age)
Intervention
(iron dose,
number of
subjects in
each group)
Control Duration of
intervention
(weeks of
months)
Outcomes Main results
group.
In anemic girls
Clerical test,
mazes and
overall test were
better in iron
treated than in
placebo. In
nonanemic girls
mazes was
better in iron
treated than in
placebo group
Soemantri et
al. 1989 [29]
Indonesia
N=130
Anemic and non
anemic children
from primary
school
10 y of age
Ferrous
sulphate 2mg
kg&d
Anemic
n=34/34
Non anemic
n=37/37
Placebo
n=59/59
Anemic
n=24/24
Non anemic
n=35/35
3 mo IQ, language
scores, math
scores, biology
scores, social
science scores
Iron
supplementation
for 3 mo
improved
learning-
achievement
scores but not IQ
in anemic
children
Sungthong et
al. 2004 [28]
Thailand
N=397
Apparently
healthy children
6-13 y of age
Ferrous
sulphate 60
mg/d
1. group: 5
days/week
n=139/140
group
once/week
n=130/134
Placebo
n=122/123
4 mo IQ, Thai language,
Mathematika
Weekly iron
supplementation
increased IQ
better than daily
supplementation
Yalcin et al.
2000 [24]
Turkey
N=24
Non anemic
infants
6 mo of age
Ferrous
sulphate
1mg/kg&d
(n=7/11)
Placebo
(n=9/13)
3 mo BSID (MDI, PDI)
assessed at 9 mo of
age
Iron
supplementation
did not change
developmental
test scores.
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Effects of iron on immunity
Table 2 shows the key characteristics of the included studies assessing immunity in children
and adolescents.
Seven studies met the selection criteria and were included in this review. Iron was given as
ferrous sulphate (10-60 mg of elemental iron daily), ferrous citrate (20 mg Fe/d), [35] or in
form of ferrous fumarate with or without multivitamins (66 mg Fe/d) [12]. In the study by
Longfils et al 10 mg of iron was given with fortified fish sauce daily as ferrous sulphate and
citrate (1st group) or NaFe-EDTA (2nd group) [27]. This study included children, adolescents
and young adults 9-21 years of age, while children in the other 6 studies were aged 1.5-13.5
years.
Four studies were carried out in Asia: two in Indonesia [36, 37] and two in Sri Lanka [38] and
Cambodia [27]. The other three studies were conducted in Benin-Africa [12], Guatemala,
South America [35] and Mexico, North America [21]. The duration of interventions ranged
from 6 weeks to 12 months (Table 2).
The effect of iron on immune function was assessed in different ways. Dossa et al (2001)
reported number of children with fever (>38oC), diarrhoea (3 or more liquid/semiliquid stools
per day) or upper respiratory tract infections (URTI) during 6 days before and 6 days after the
supplementation period [12]. Rosado et al. (1997) measured the same parameters twice
weekly during the whole supplementation period, e.g. 12 months [21]. In addition to these
parameters assessed weekly during the intervention, Longfils et al. (2008) measured C
reactive protein (CRP) [27]. Rosales et al. (2004) measured CRP, alpha-1-acid glycoprotein
(AGP) and alpha-1-antil-chymotrypsin (ACT) as markers of infections before and after iron
supplementation [35]. In these four studies iron supplementation had no detectable effect on
the measured markers of immune function. De Silva el al. (2003) assessed the number of
infectious episodes and the number of sick days [38], while Chwang et al. (1988) measured
morbidity scores of acute and chronic diseases, scored from 0 (healthy) to 3 (>3 days
absence from school due to disease) [37]. Palupi et al (1997) used parasite infections as
indicator of immune function, assessed as number of eggs per gram of stool at the beginning
and the end of the study [36]. In these three studies iron supplementation significantly
improved the chosen measures of immune function in children.
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Table 2: Main characteristics and results of trials assessing effects of iron supply on immunity
Author,year
of
publication,
country
Population
characteristics
(number of
subjects, age)
Intervention
(iron dose, number
of subjects in each
group)
Control Duration of
intervention
(weeks of
months)
Outcomes Main results
Chwang et
al. 1988
Indonesia
[37]
N=119
Anemic and
non- anemic
8.2-13.5 y of
age
Ferrous sulphate
2mg/kg&d
n=59/59
Placebo
n=60/60
3 mo Morbidity
score of acute
or chronic
diseases
Iron
supplementation
improved level of
morbidity in
anemic but not in
non anemic
children
Dossa et al.
2001 [12]
Benin
N=154
Stunted,
anemic children
1.5-2.5 y of age
1. group: Ferrous
fumarate 66 mg/d
n=37/35
2. group: Ferrous
fumarate+
multivitamines 66
mg/d n=40/39
1. Group:
Placebo
n=39/39
2. Group:
Multivitamines
n=38/37
6 weeks Diarrhea,
fever, URTI
The morbidity
status was
comparable in all
groups, before
and after
supplementation.
Supplementation
with iron with or
without
multivitamin-
multiminerals
failed to improve
immune function
in children.
Longfils et
al. 2008 [27]
Cambodia
N=140
Anemic
subjects
9-21 y of age
Ferrous sulphate
10mg/d
1.group-
FeSO4+citrate
containing 10 mg
elemental iron
n=47/48
2.group-NaFe-EDTA
containing 10 mg
elemental iron
n=47/48
Placebo
n=45/46
5.25 mo Diarrhea,
URTI, CRP
Iron-fortified
Khmer fish sauce
added to Khmer
food did not
affect the
immune function
in children and
adolescents.
Palupi et al.
1997 [36]
Indonesia
N=299
2-5 y of age
Ferrous sulphate
30mg/d
1.group-ferous
sulphate+aldendazole
(400mg)
n=95/95
2.group-ferous
sulphate n=96/96
Placebo
n=98/98
2.25 mo Parasite
infections
Iron
supplementations
administered
once weekly
reduced parasite
infection in an
Indonesian
community
Rosado et
al. 1997 [21]
Mexico
N=108
18-36 mo of
age
Ferrous sulphate
20mg/d
n=53/53
Placebo
n=55/55
12 mo Diarrhea, URTI Iron
supplementation
did not
significantly
affect morbidity
Rosales et
al. 2004 [35]
Guatemala
N=77
Non anemic
8-11 y of age
Ferrous citrate
20mg/d
n=15/15
Placebo
n=14/14
2 mo CRP, AGP,
ACT
Iron
supplementation
did not improve
inflammation
de Silva et
al. 2003 [38]
Sri Lanka
N=434
Children with or
without
infection
5-10 y of age
Ferrous sulphate
60mg/d
1.Children with
infection n=127/127
2.Children without
infection n=134/134
1.Placebo-
children with
infection
n=52/52
2. Placebo-
children
without
infection
n=50/50
2 mo URTI and
gastrointestinal
infections
In both the
infection group
and the control
group, the mean
number of URTI
episodes and the
total number of
days sick with an
URTI during the
period of
intervention were
significantly lower
in the children
who received iron
supplements
than in those who
received placebo.
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Quality of studies included
Table 3 summarizes the methodological quality of the included studies assessing
neurodevelopment and immunity, assessed as described in the section “Methods”. The
results clearly show a high risk of bias in most of the studies. Only 2 studies [13, 25] had a
low risk of bias. Two studies had a moderate risk of bias [8, 28]. The main reasons for having
a high risk of bias were an inadequate sequence generation and/or allocation and the study
funders. Among the trials dealing with immunity, only one study out of 7 was assessed as
having a moderate risk of bias. Six studies had a high risk of bias, mainly due to inadequate
sequence generation and allocation.
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Table 3: Assessment of methodological quality of included RCTs on effects of iron supply
Study
(Author,
year)
Adequate
sequence
generation
Allocation
concealment
adequate
Blinding
adequate
Dropouts
adequate
and outcome
data
complete
Funder
adequate
Lack of
other
potential
threats to
validity
Overall
risk of
bias
Neurovelopment including cognitive function and psychomotor development
Aukett  and
Parks 1986
[33]
Unclear Yes Yes Yes Unclear Yes High
Bruner et al.
1996 [8]
Yes Yes Yes Yes No Yes Moderate
Idjradinata
and Pollitt
1993 [13]
Yes Yes Yes Yes Yes Yes Low
Kashyap et
al. 1987 [30]
Unclear Unclear Unclear No Yes Yes High
Konofal et al.
2008 [32]
Unclear Unclear Yes Yes Unclear Unclear High
Lind et al.
2004 [25]
Yes Yes Yes Yes Yes Unclear Low
Lozoff et al.
1982 [26]
Unclear Unclear Yes Yes Yes Unclear High
Metallinos-
Katsaras et
al. 2004 [34]
Unclear Yes Yes Yes No Yes High
Pollitt et al.
1989 [17]
Unclear Unclear Yes Unclear Yes Yes High
Seshadri et
al. 1989 [31]
Unclear Unclear Unclear Yes Unclear Yes High
Soemantri et
al. 1989 [29]
Unclear Unclear Yes Yes Yes Yes High
Sungthong et
al. 2004 [28]
Yes Unclear Yes Yes Yes Yes Moderate
Yalcin et al.
2000 [24]
Unclear Unclear No Yes Unclear Unclear High
Immunity
Chwang et
al. 1988 [37]
Unclear Unclear Yes Yes Yes Yes High
Dossa et al.
2001 [12]
Yes No No Yes Yes Yes High
Longfils et al.
2008 [27]
Unclear Unclear Yes Yes No Yes High
Palupi et al.
1997[36]
Unclear Unclear Yes Yes No Yes High
Rosado et al.
1997 [21]
Unclear Yes Yes Yes Yes Yes Moderate
Rosales et al.
2004 [35]
Unclear Yes No Yes Unclear Yes High
de Silva et al.
2003 [38]
Unclear Unclear Yes Unclear Yes Yes High
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DISCUSSION
Evidence
This review of 20 RCTs has assessed the effects of iron supplementation on measures of
neurodevelopment, including measures of cognition and psychomotor development, and on
immunity, in infants, children and adolescents from birth to 18 years of age. The
overwhelming feature of this review is the utter paucity of relevant studies that could be
identified and included in the review, especially for infants until 12 months of age.
Only one study identified provided iron supplements for a short period of time (one week)
[26]. Based on this single study, there is no evidence of a positive effect of short term
supplementation in the mental and psychomotor development of anemic infants and children
with and without IDA of 6 to 24 months of age.
For children aged 1 to 5 years of age, there is some evidence from 3 RCTs which show a
benefit of iron supplementation during 2 to 4 months on the mental and psychomotor
development of both anemic and non anemic children [13, 34] and of anemic children [33].
Seven RCTs in anemic and non-anemic children over 5 years of age provided evidence for a
positive effect of iron supplementation on different measures of cognition [8, 17, 28-32].
Given the data base available, it is not possible to derive firm evidence-based conclusions on
the effect of iron intake on neurodevelopment. The data on iron status and morbidity are
even more controversial. One important reason for this lack of evidence is that a large
number of the trials originally had to be excluded because they did not have an adequate
control group according to our criteria. This was especially relevant for interventions with
fortified formula and fortified foods, which limited the review to supplementation trials except
for one trial with a fortified food [27]. Furthermore, the presence of other confounding
variables, such as other nutritional deficiencies, low socioeconomic status, studies carried
out in areas with endemic malaria etc. could markedly have influenced the obtained results.
The large heterogeneity of outcomes reported related to immunity impedes any comparison
of studies.
Another remarkable feature of the collected studies is the heterogeneity of study populations.
This further complicated matters by making it difficult or impossible to compare and combine
the available results in a meaningful way. The heterogeneity of outcome measures precludes
pooling study results quantitatively or even qualitatively in the case of immunity. The
assessment of validity shows that the methodological quality of most studies is limited.
Comparison with other reviews
In 2005, Sachdev and collaborators published a systematic review with a meta-analysis
examining the effects of iron supplementation in relation to development in children [15]. The
review included 17 trials of oral iron supplementation, fortified milks and cereal, and
parenteral iron (all RCTs) involving 3646 participants. The authors concluded that iron
supplementation had modest but significant beneficial effects on mental development for
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children who were anemic or iron deficient at baseline and for all children >7 years old,
particularly for IQ scores. In younger children (aged <27 months), no effect of iron
supplementation on mental development was detected. Motor development was not found to
be improved through iron supplementation.
An extensive review by Iannotti et al. on the benefits and risks of iron supplementation of
infants and children under 5 years of age in developing countries, published in 2006,
concluded that providing additional iron via daily or weekly supplementation to iron-deficient
children under 5 years may have some positive effects on developmental indicators,
especially among children who are anemic or iron deficient at baseline [39].
A Cochrane review by Logan et al (2001) aimed to assess the effects of iron
supplementation provided to iron deficient infants and children under 3 years of age,
beginning supplementation before 1 year of age, on measures of psychomotor development
or cognitive function [40]. 7 RCTs providing oral or intramuscular iron were included in this
review, 5 of which assessed psychomotor development between 5 and 11 days of
commencement of therapy. It was concluded that there was no convincing evidence that
administration of iron improves scores on tests of psychomotor development within 6-11
days of treatment. The effect of longer interventions unfortunately remained unclear from the
results of the other 2 studies where the assessment was done more than 30 days after
commencement of therapy.
A recent review with meta-analysis by Szajewska et al. (2010) analysed the effects of non-
anemic infants and young children on the mental performance and psychomotor
development of children (<3 years) [41]. The included RCTs did not individually show a
beneficial effect of iron supplementation during early life. The authors performed 2 meta-
analyses of 3 RCTs involving 561 infants and children. It was concluded that iron
supplementation in infants may positively influence children’s psychomotor development,
whereas it does not seem to alter their mental development or behaviour.
Falkingham et al. (2010) recently published a systematic review assessing the effects of iron
supplementation on cognition in older children (>6 years) and adults [42]. They included 14
RCTs and concluded that iron supplementation improved attention and concentration in all
studies irrespective of baseline iron status. In anemic groups of children supplementation
improved IQ but had no effect on non-anemic participants. No effect of iron supplementation
was found on memory, psychomotor skills or scholastic achievement. However, the authors
emphasised the limited number of included studies, which were generally conducted in small
samples of subjects, had a short duration and were methodologically weak.
No published reviews on the effect of iron on immunity could be identified.
Strengthens and weakness of this review
In children and adolescents, 4 out of 10 studies on cognitive function and 4 out of 7 studies
on immune function, included in this review had a supplementation period shorter than 12
weeks of supplementation (Tables 1 and 2), which is thought to be sufficient to alter the iron
status. Some studies were included of too short a duration; these could possibly negate the
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effects of iron supplementation, but in this case, these studies showed similar effects on
cognition compared to studies with longer supplementation periods. Additionally, a 3-month
long study [29] showed no effects of supplementation on IQ in anemic (and non anemic)
children, which the authors explained by several factors such as mucosal block or other
unidentified causes that were not detected during the study (e.g. genetic factors that control
absorption). Although a much longer duration of intervention is probably needed for
outcomes such as scholastic achievement, where iron status at learning may be different
from iron status at assessment of performance [42], we found improved learning results after
iron supplementation.
Comparing morbidity outcomes in studies shorter and longer than 12 weeks of
supplementation, similarly inconsistent results are found compared to cognitive outcomes. In
the longest study, for instance, which lasted 12 months, Rosado et al. (1997) did not find
significantly lower frequency of infections in the iron supplemented group, while de Silva et
al. (2003) reported significantly less acute respiratory infections after 8 weeks of iron
supplementation than in the placebo group.
An important weakness of this review is the high risk of bias of most of the included papers.
The sequence generation and/or allocation were not well addressed in 9 and 8 papers
respectively, as well as funders in 4 studies on cognition (Table 3). Only 2 studies were
assessed as having a low risk of bias. A high risk of bias was assessed in 6 out of 7 studies,
due to inadequate sequence generation (6), allocation (5) and funding (3 studies).
The tests for assessment of neurodevelopment are similar in infants and young children
(Bayley test) while in older children the comparison is much more complicated. Immune
function was also assessed in different ways. Different iron status at baseline (anemic, non
anemic and non anemic iron deficient subjects), and different socioeconomic status of the
participants make it difficult to assess the effects of iron on cognitive and immune functions.
Recommendations for practice and research
Until more convincing evidence exist that iron supplementation can significantly improve
neurodevelopment, including measures of cognitive function and psychomotor development
in infants, children and adolescents, policy should focus on prevention of iron deficiency
anemia.
Randomised controlled trials in infants, children and adolescents should be conducted in a
way that facilitates comparison with other studies and metaanalysis. Reporting those studies
in a standardised way would also contribute to a more evidence based nutrition.
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10 APPENDIX A: SEARCH STRATEGIES
10.1 FINAL IRON SEARCH STRATEGY – EMBASE
Date of search: 6/02/2009 and 6/02/2010
# Searches Results SearchType
1
infant nutrition.mp. [mp=title, abstract, subject headings,
heading word, drug trade name, original title, device
manufacturer, drug manufacturer name]
2103 Advanced
2 exp infant nutrition/ 25456 Advanced
3 Infant Nutrition/ 1940 Advanced
4 artificial milk/ or breast milk/ or bottle feeding/ or breast feeding/ 23313 Advanced
5 lactation/ 12685 Advanced
6 random*.ti,ab. 389782 Advanced
7 factorial*.ti,ab. 8131 Advanced
8 (crossover* or cross over* or cross-over*).ti,ab. 39188 Advanced
9 placebo*.ti,ab. 109036 Advanced
10 (doubl* adj blind*).ti,ab. 84173 Advanced
11 (singl* adj blind*).ti,ab. 7399 Advanced
12 Crossover Procedure/ 20937 Advanced
13 Double Blind Procedure/ 71265 Advanced
14 Randomized Controlled Trial/ 165330 Advanced
15 Single Blind Procedure/ 7943 Advanced
16 animal/ or nonhuman/ or animal experiment/ 3415144 Advanced
17 human/ 6387488 Advanced
18
((iron or ferrous or ferric or ferr*) adj3 (intake* or diet* or
supplement* or deplet* or status or expos* or
concentration*)).ti,ab.
12627 Advanced
19 *Ferritin Blood Level/ 511 Advanced
20 *Transferrin Receptor/ 1991 Advanced
21 *Hemoglobin/ 12370 Advanced
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# Searches Results SearchType
22
((serum adj3 ferritin) or (plasma adj3 ferritin) or (serum adj3
apoferritin) or (plasma adj3 apoferritin) or (serum adj3
"transferrin receptor*") or (plasma adj3 "transferrin receptor*") or
(serum adj3 TFR*) or (plasma adj3 TFR*)).mp. [mp=title,
abstract, subject headings, heading word, drug trade name,
original title, device manufacturer, drug manufacturer name]
5311 Advanced
23 (hemoglobin* or haemoglobin*).ti,ab. 62809 Advanced
24 *Iron Intake/ or *Iron Depletion/ or *Iron Deficiency/ 3095 Advanced
25 (iron or ferrous or ferric or ferr*).ti,ab. 96859 Advanced
26 (intake* or diet* or fortif* or supplement* or deplet* or status orconcentration* or expos*).ti,ab. 1855418 Advanced
27 supplementation/ or diet supplementation/ or dietary intake/ orexp diet restriction/ or exp food intake/ or exp mineral intake/ 179562 Advanced
28 exp nutritional status/ or nutritional deficiency/ 21122 Advanced
29 11 or 8 or 12 or 14 or 7 or 13 or 6 or 9 or 15 or 10 502578 Advanced
30 16 and 17 527284 Advanced
31 16 not 30 2887860 Advanced
32 29 not 31 440615 Advanced
33 23 or 21 or 22 or 20 or 19 69947 Advanced
34 27 or 26 or 28 1932328 Advanced
35 33 or 34 1974813 Advanced
36 35 and 25 41757 Advanced
37 24 or 18 or 36 42652 Advanced
38 32 and 37 2191 Advanced
39 4 or 34 or 3 or 5 1941284 Advanced
40 33 or 39 1983747 Advanced
41 25 and 40 41853 Advanced
42 18 or 24 or 41 42746 Advanced
43 42 and 32 2193 Advanced
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10.2 FINAL IRON SEARCH STRATEGY – MEDLINE
Date of search 6/02/2009 and 6/02/2010
# Searches Results Search Type
1 randomized controlled trial.pt. 261515 Advanced
2 controlled clinical trial.pt. 77893 Advanced
3 randomized.ab. 172980 Advanced
4 clinical trials as topic.sh. 140006 Advanced
5 randomly.ab. 125849 Advanced
6 randomised.ab. 33552 Advanced
7 (animals not (human and animals)).sh. 4293014 Advanced
8 ((iron or ferric or ferrous or ferr*) adj3 (intake* or diet* or supplement*or deplet* or status or expos* or concentration*)).ti,ab. 14306 Advanced
9 (hemoglobin* or haemoglobin*).ti,ab. 84956 Advanced
10
((serum adj3 ferritin) or (plasma adj3 ferritin) or (serum adj3
apoferritin) or (plasma adj3 apoferritin) or (serum adj3 "transferrin
receptor*") or (plasma adj3 "transferrin receptor*") or (serum adj3
TFR*) or (plasma adj3 TFR*)).ti,ab.
6042 Advanced
11 *iron, dietary/ 806 Advanced
12 (iron or ferrous or ferric or ferr*).ti,ab. 116185 Advanced
13 (intake* or diet* or fortif* or supplement* or deplet* or status orconcentration* or expos*).ti,ab. 2148582 Advanced
14
nutritional support/ or dietary supplements/ or nutritional
requirements/ or exp nutritional status/ or exp deficiency diseases/ or
supplementation/
108850 Advanced
15
diet supplementation/ or dietary intake/ or exp diet restriction/ or exp
mineral intake/ or diet/ or food, fortified/ or nutrition assessment/ or
nutritive value/
94854 Advanced
16 6 or 4 or 1 or 3 or 2 or 5 578036 Advanced
17 16 not 7 516057 Advanced
18 10 or 9 89036 Advanced
19 13 or 15 or 14 2231529 Advanced
20 11 or 12 116199 Advanced
21 18 or 19 2289421 Advanced
22 21 and 20 46409 Advanced
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# Searches Results Search Type
23 22 or 8 46409 Advanced
24 23 and 17 2311 Advanced
25 Breast Feeding/ or exp Infant Food/ 26392 Advanced
26 Bottle Feeding/ 2725 Advanced
27 25 or 26 27172 Advanced
28 Infant Formula/ 1023 Advanced
29 27 or 28 27172 Advanced
30 19 or 29 2248563 Advanced
31 18 or 30 2306432 Advanced
32 8 or 31 2306432 Advanced
33 32 and 20 46494 Advanced
34 33 and 17 2321 Advanced
10.3 FINAL IRON SEARCH STRATEGY – COCHRANE
Date of search: 9/02/2009 and 6/02/2010
ID Search Hits
#1 iron 3316
#2 MeSH descriptor Iron, Dietary explode all trees 162
#3 MeSH descriptor Iron explode tree 4 1320
#4 (#1 OR #2 OR #3) 3316
#5 MeSH descriptor Hemoglobins, this term only 1976
#6 hemoglobin* or haemoglobin* 9043
#7 ferritin or apoferritin 1007
#8 MeSH descriptor Ferritins explode all trees 580
#9 "transferrin receptor" 104
#10 TfR 31
#11 MeSH descriptor Receptors, Transferrin, this term only 62
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#12 (#5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11) 9474
#13 intake* or diet* or fortif* or supplement* or deplet* or status or concentration* orexpos* 168530
#14 (#12 OR #13) 172972
#15 (#14 AND #4) 2603
#16 "kidney disease" or hemodialys* or dialys* or "renal failure" or "heart failure" or CKDor chemotherap* or cancer* or malignanc* or thalassemia or "sickle cell" 79705
#17
(#15 AND NOT ( "kidney disease" OR hemodialys* OR dialys* OR "renal failure" OR
"heart failure" OR CKD OR chemotherap* OR cancer* OR malignanc* OR
thalassemia OR "sickle cell" ))
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